activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650423	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650423	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650424	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650425	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650426	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650427	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650428	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL3988	Homo sapiens	Kd		
	1650429	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL3988	Homo sapiens	Kd	uM	1.3
Not Active	1650430	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1650431	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3988	Homo sapiens	Kd		
	1651456	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	710.0	CHEMBL3988	Homo sapiens	Kd	uM	0.71
Not Active	1651457	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1651458	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3988	Homo sapiens	Kd		
	1651459	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	1651460	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	3900.0	CHEMBL3988	Homo sapiens	Kd	uM	3.9
Not Active	1651461	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1651462	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1651463	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Active	1651464	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3988	Homo sapiens	Kd		
	1651465	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	4300.0	CHEMBL3988	Homo sapiens	Kd	uM	4.3
	1651466	CHEMBL860664	Average Binding Constant for EPHA4; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	310.0	CHEMBL3988	Homo sapiens	Kd	uM	0.31
	2081821	CHEMBL929861	Inhibition of EphB4 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3988	Homo sapiens	Inhibition	%	20.0
	2147249	CHEMBL922824	Activity of human EphA4 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	90.0	CHEMBL3988	Homo sapiens	Activity	%	90.0
	2470171	CHEMBL1034120	Inhibition of EPHA4 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3988	Homo sapiens	INH	%	10.0
Not Evaluated	2476657	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2476860	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2478699	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3988	Homo sapiens	Activity		
	2479540	CHEMBL988934	Binding affinity to human EPHA4	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	5.0	CHEMBL3988	Homo sapiens	Kd	nM	5.0
Not Evaluated	2479757	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2480554	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3988	Homo sapiens	Activity		
	2480756	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	3.6	CHEMBL3988	Homo sapiens	Activity	%	3.6
Not Evaluated	2577378	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3988	Homo sapiens	Activity		
	2584872	CHEMBL955782	Inhibition of EphA4	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	2584900	CHEMBL955782	Inhibition of EphA4	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	5600.0	CHEMBL3988	Homo sapiens	IC50	uM	5.6
	2593583	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	21.0	CHEMBL3988	Homo sapiens	Activity	%	21.0
Active	2593786	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2593849	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2594052	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2594995	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3988	Homo sapiens	Activity		
	2595264	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	1.1	CHEMBL3988	Homo sapiens	Activity	%	1.1
Not Evaluated	2596192	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2596395	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2597664	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Evaluated	2597867	CHEMBL1024909	Binding affinity to human EPHA4 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3988	Homo sapiens	Activity		
	2721019	CHEMBL1061756	Inhibition of EphA4 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	2904897	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904898	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904899	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	400.0	CHEMBL3988	Homo sapiens	Kd	nM	400.0
	2904900	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904901	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	2900.0	CHEMBL3988	Homo sapiens	Kd	nM	2900.0
	2904902	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904903	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904904	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904905	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3600.0	CHEMBL3988	Homo sapiens	Kd	nM	3600.0
	2904906	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904907	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904908	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1.2	CHEMBL3988	Homo sapiens	Kd	nM	1.2
	2904909	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904910	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904911	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904912	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904913	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904914	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904915	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904916	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904917	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904918	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904919	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904920	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	420.0	CHEMBL3988	Homo sapiens	Kd	nM	420.0
	2904921	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904922	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904923	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904924	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904925	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904926	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904927	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904928	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3988	Homo sapiens	Kd	nM	3000.0
	2904929	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	290.0	CHEMBL3988	Homo sapiens	Kd	nM	290.0
	2904930	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904931	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904932	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4300.0	CHEMBL3988	Homo sapiens	Kd	nM	4300.0
	2904933	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	2904934	CHEMBL1061895	Binding constant for EPHA4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1600.0	CHEMBL3988	Homo sapiens	Kd	nM	1600.0
	2921357	CHEMBL1056101	Inhibition of EPHA4 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	22.0	CHEMBL3988	Homo sapiens	Activity	%	22.0
	2926275	CHEMBL1046773	Inhibition of EphA4 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	3.3	CHEMBL3988	Homo sapiens	IC50	nM	3.3
	3052594	CHEMBL1037135	Residual activity of EPHA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	92.0	CHEMBL3988	Homo sapiens	Residual activity	%	92.0
	3053903	CHEMBL1044303	Residual activity of EPHA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	47.0	CHEMBL3988	Homo sapiens	Residual activity	%	47.0
	3054155	CHEMBL1050283	Residual activity of EPHA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL3988	Homo sapiens	Residual activity	%	103.0
	3055442	CHEMBL1037135	Residual activity of EPHA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	102.0	CHEMBL3988	Homo sapiens	Residual activity	%	102.0
	3055694	CHEMBL1044303	Residual activity of EPHA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	112.0	CHEMBL3988	Homo sapiens	Residual activity	%	112.0
	3056999	CHEMBL1050283	Residual activity of EPHA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL3988	Homo sapiens	Residual activity	%	93.0
	3058319	CHEMBL1037135	Residual activity of EPHA4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL3988	Homo sapiens	Residual activity	%	94.0
	3058571	CHEMBL1044303	Residual activity of EPHA4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	94.0	CHEMBL3988	Homo sapiens	Residual activity	%	94.0
	3072917	CHEMBL1050283	Residual activity of EPHA4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL3988	Homo sapiens	Residual activity	%	93.0
	3213800	CHEMBL1108387	Inhibition of EPHA4 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	102.0	CHEMBL3988	Homo sapiens	INH	%	102.0
	3224808	CHEMBL1099645	Inhibition of EPHA4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3225058	CHEMBL1099645	Inhibition of EPHA4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3331918	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3333333	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3334738	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3336158	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3337513	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3337762	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3339096	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3340398	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3340686	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3342102	CHEMBL1169208	Inhibition of EPHA4 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	3358553	CHEMBL1174398	Inhibition of EPHA4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL3988	Homo sapiens	INH	%	0.0
	3358995	CHEMBL1174398	Inhibition of EPHA4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.25	CHEMBL3988	Homo sapiens	INH	%	0.25
	3443385	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	95.0	CHEMBL3988	Homo sapiens	INH	%	95.0
	3443602	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	69.0	CHEMBL3988	Homo sapiens	INH	%	69.0
	3444757	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	68.0	CHEMBL3988	Homo sapiens	INH	%	68.0
	3445104	CHEMBL1244815	Binding affinity to EPHA4	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1700.0	CHEMBL3988	Homo sapiens	Kd	nM	1700.0
	3445381	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	62.0	CHEMBL3988	Homo sapiens	INH	%	62.0
	3445598	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	27.0	CHEMBL3988	Homo sapiens	INH	%	27.0
	3445807	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	91.0	CHEMBL3988	Homo sapiens	INH	%	91.0
	3445997	CHEMBL1244418	Inhibition of EPHA4 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	63.0	CHEMBL3988	Homo sapiens	INH	%	63.0
	3448412	CHEMBL1244815	Binding affinity to EPHA4	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	3448737	CHEMBL1244815	Binding affinity to EPHA4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	3449421	CHEMBL1244815	Binding affinity to EPHA4	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3988	Homo sapiens	Kd	nM	3000.0
	3449648	CHEMBL1244815	Binding affinity to EPHA4	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	3450327	CHEMBL1244815	Binding affinity to EPHA4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	3450980	CHEMBL1244815	Binding affinity to EPHA4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	uM	10.0
	3463218	CHEMBL1252306	Inhibition of EPHA4 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-4.0	CHEMBL3988	Homo sapiens	INH	%	-4.0
	3463437	CHEMBL1252306	Inhibition of EPHA4 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	9.0	CHEMBL3988	Homo sapiens	INH	%	9.0
	3463981	CHEMBL1252306	Inhibition of EPHA4 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	11.0	CHEMBL3988	Homo sapiens	INH	%	11.0
	5121172	CHEMBL1645950	Inhibition of human EphA4 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	127.0	CHEMBL3988	Homo sapiens	INH	%	127.0
	5152479	CHEMBL1656391	Inhibition of EPHA4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	5152504	CHEMBL1656391	Inhibition of EPHA4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	5243694	CHEMBL1685657	Inhibition of EphA4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	99.0	CHEMBL3988	Homo sapiens	INH	%	99.0
	5243802	CHEMBL1685906	Inhibition of EphA4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	68.0	CHEMBL3988	Homo sapiens	INH	%	68.0
	5243915	CHEMBL1685657	Inhibition of EphA4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	98.0	CHEMBL3988	Homo sapiens	INH	%	98.0
	5244023	CHEMBL1685906	Inhibition of EphA4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	72.0	CHEMBL3988	Homo sapiens	INH	%	72.0
	5244896	CHEMBL1685657	Inhibition of EphA4 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	99.0	CHEMBL3988	Homo sapiens	INH	%	99.0
	5245004	CHEMBL1685906	Inhibition of EphA4 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	103.0	CHEMBL3988	Homo sapiens	INH	%	103.0
	5245155	CHEMBL1685657	Inhibition of EphA4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	120.0	CHEMBL3988	Homo sapiens	INH	%	120.0
	5245985	CHEMBL1685906	Inhibition of EphA4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	122.0	CHEMBL3988	Homo sapiens	INH	%	122.0
	6341048	CHEMBL1828217	Activity of EPHA4 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	6352203	CHEMBL1825740	Inhibition of EPHA4 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	6386342	CHEMBL1839873	Inhibition of recombinant EPHA4	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	7567350	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7567809	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7568306	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	8.3	CHEMBL3988	Homo sapiens	Kd	nM	8.3
	7568738	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7569323	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7569813	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7570276	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7570703	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7571299	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7571314	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	360.0	CHEMBL3988	Homo sapiens	Kd	nM	360.0
	7571790	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7572253	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7572669	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	910.0	CHEMBL3988	Homo sapiens	Kd	nM	910.0
	7573295	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1.2	CHEMBL3988	Homo sapiens	Kd	nM	1.2
	7573771	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	7700.0	CHEMBL3988	Homo sapiens	Kd	nM	7700.0
	7574240	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7574648	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7574816	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7575277	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7575748	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7576213	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7576621	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4000.0	CHEMBL3988	Homo sapiens	Kd	nM	4000.0
	7576790	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7577249	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1.9	CHEMBL3988	Homo sapiens	Kd	nM	1.9
	7577727	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7578197	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	980.0	CHEMBL3988	Homo sapiens	Kd	nM	980.0
	7578602	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1600.0	CHEMBL3988	Homo sapiens	Kd	nM	1600.0
	7578798	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7579172	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	2900.0	CHEMBL3988	Homo sapiens	Kd	nM	2900.0
	7579622	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7580096	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7581156	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7581541	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7581986	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7582479	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7582879	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4300.0	CHEMBL3988	Homo sapiens	Kd	nM	4300.0
	7583502	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7583899	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7584344	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7584373	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7584835	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	150.0	CHEMBL3988	Homo sapiens	Kd	nM	150.0
	7585239	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7585832	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7586240	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7586715	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7587169	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7588223	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7588694	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7589145	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7589316	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7589740	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1700.0	CHEMBL3988	Homo sapiens	Kd	nM	1700.0
	7590207	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7590681	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7591132	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7591289	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7591711	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7592183	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7592656	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	420.0	CHEMBL3988	Homo sapiens	Kd	nM	420.0
	7593109	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	18.0	CHEMBL3988	Homo sapiens	Kd	nM	18.0
	7593256	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	400.0	CHEMBL3988	Homo sapiens	Kd	nM	400.0
	7593691	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	8900.0	CHEMBL3988	Homo sapiens	Kd	nM	8900.0
	7594163	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7594636	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	330.0	CHEMBL3988	Homo sapiens	Kd	nM	330.0
	7595224	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7595668	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3600.0	CHEMBL3988	Homo sapiens	Kd	nM	3600.0
	7596142	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7596618	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3000.0	CHEMBL3988	Homo sapiens	Kd	nM	3000.0
	7597196	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7597649	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7598122	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7598150	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3988	Homo sapiens	Kd	nM	10000.0
	7598592	CHEMBL1908649	Binding constant for EPHA4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	290.0	CHEMBL3988	Homo sapiens	Kd	nM	290.0
	7959741	CHEMBL1932845	Inhibition of EPHA4	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3988	Homo sapiens	IC50	uM	30.0
	7959742	CHEMBL1932845	Inhibition of EPHA4	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	70.0	CHEMBL3988	Homo sapiens	IC50	uM	0.07
	7969677	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Nc1n[nH]c2ncc3c(c12)CCCCCC3		CHEMBL1927251	=	Inhibition	%	80.0	CHEMBL3988	Homo sapiens	INH	%	80.0
	7969678	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Cc1cc(C)c2c(NC(=O)c3ccccc3)n[nH]c2n1		CHEMBL1927252	=	Inhibition	%	10.0	CHEMBL3988	Homo sapiens	INH	%	10.0
	7969679	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CC1(C)Cc2c(c(-c3ccccc3)nc3[nH]nc(N)c23)CO1		CHEMBL1927253	=	Inhibition	%	90.0	CHEMBL3988	Homo sapiens	INH	%	90.0
	7969680	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CC1(C)Cc2c(c(-c3ccco3)[nH]c3nnc(N)c2-3)CO1		CHEMBL1525857	=	Inhibition	%	75.0	CHEMBL3988	Homo sapiens	INH	%	75.0
	7969681	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CC(C)c1nc2[nH]nc(N)c2c2c1COC(C)(C)C2		CHEMBL1927254	=	Inhibition	%	82.0	CHEMBL3988	Homo sapiens	INH	%	82.0
	7969682	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CCCc1nc2[nH]nc(N)c2c2c1COC(C)(C)C2		CHEMBL1312110	=	Inhibition	%	77.0	CHEMBL3988	Homo sapiens	INH	%	77.0
	7969683	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CC1(C)Cc2c(c(-c3ccccc3)nc3[nH]nc(N)c23)CS1		CHEMBL1927255	=	Inhibition	%	87.0	CHEMBL3988	Homo sapiens	INH	%	87.0
	7969684	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Cc1nc2[nH]nc(N)c2c2c1CSC(C)(C)C2		CHEMBL1927256	=	Inhibition	%	70.0	CHEMBL3988	Homo sapiens	INH	%	70.0
	7969685	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CN1CCc2c(c(NCc3ccccc3)nc3[nH]nc(N)c23)C1		CHEMBL1927257	=	Inhibition	%	33.0	CHEMBL3988	Homo sapiens	INH	%	33.0
	7969686	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CCN(CC)c1nc2[nH]nc(N)c2c2c1CN(C)CC2		CHEMBL1927258	=	Inhibition	%	5.0	CHEMBL3988	Homo sapiens	INH	%	5.0
	7969687	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CN1CCc2c(c(N3CCOCC3)nc3[nH]nc(N)c23)C1		CHEMBL1927259	=	Inhibition	%	0.0	CHEMBL3988	Homo sapiens	INH	%	0.0
	7969688	CHEMBL1930700	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 200 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	CN1CCc2c(c(NCCO)nc3[nH]nc(N)c23)C1		CHEMBL1927260	=	Inhibition	%	0.0	CHEMBL3988	Homo sapiens	INH	%	0.0
	7969689	CHEMBL1930701	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation at 500 uM after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Nc1n[nH]c2ncc3c(c12)CCCC3		CHEMBL1927250	=	Inhibition	%	80.0	CHEMBL3988	Homo sapiens	INH	%	80.0
	7969715	CHEMBL1931215	Inhibition of EPHA4 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	6.0	CHEMBL3988	Homo sapiens	Activity	%	6.0
	7969814	CHEMBL1930640	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Nc1n[nH]c2nc(-c3ccccc3Cl)c3c(c12)CCCC3		CHEMBL1927261	=	IC50	nM	8100.0	CHEMBL3988	Homo sapiens	IC50	uM	8.1
	7969815	CHEMBL1930640	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	IC50	nM	4500.0	CHEMBL3988	Homo sapiens	IC50	uM	4.5
	7969816	CHEMBL1930640	Inhibition of his-tagged EPHA4-mediated poly(Glu,Tyr) phosphorylation after 75 mins using E4:Y1 as substrate by fluorescence assay	B	Cc1ccccc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927263	=	IC50	nM	2000.0	CHEMBL3988	Homo sapiens	IC50	uM	2.0
	8013062	CHEMBL1947849	Inhibition of EphA4 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	8047105	CHEMBL1958846	Inhibition of EPHA4 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	8061370	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.74	CHEMBL3988	Homo sapiens	Inhibition	%	4.74
	8061547	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	21.67	CHEMBL3988	Homo sapiens	Inhibition	%	21.67
	8061654	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	7.5	CHEMBL3988	Homo sapiens	Inhibition	%	7.5
	8061878	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	13.28	CHEMBL3988	Homo sapiens	Inhibition	%	13.28
	8062069	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.07	CHEMBL3988	Homo sapiens	Inhibition	%	5.07
	8062409	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.88	CHEMBL3988	Homo sapiens	Inhibition	%	7.88
	8062571	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	10.94	CHEMBL3988	Homo sapiens	Inhibition	%	10.94
	8062893	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-7.03	CHEMBL3988	Homo sapiens	Inhibition	%	-7.03
	8063249	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	21.95	CHEMBL3988	Homo sapiens	Inhibition	%	21.95
	8063416	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.57	CHEMBL3988	Homo sapiens	Inhibition	%	6.57
	8063748	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	7.63	CHEMBL3988	Homo sapiens	Inhibition	%	7.63
	8063930	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.23	CHEMBL3988	Homo sapiens	Inhibition	%	6.23
	8064269	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.19	CHEMBL3988	Homo sapiens	Inhibition	%	4.19
	8064479	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.85	CHEMBL3988	Homo sapiens	Inhibition	%	1.85
	8064841	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.72	CHEMBL3988	Homo sapiens	Inhibition	%	2.72
	8065007	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	10.18	CHEMBL3988	Homo sapiens	Inhibition	%	10.18
	8065347	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	7.96	CHEMBL3988	Homo sapiens	Inhibition	%	7.96
	8065522	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.56	CHEMBL3988	Homo sapiens	Inhibition	%	4.56
	8065746	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	7.91	CHEMBL3988	Homo sapiens	Inhibition	%	7.91
	8065861	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.68	CHEMBL3988	Homo sapiens	Inhibition	%	4.68
	8066071	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-8.34	CHEMBL3988	Homo sapiens	Inhibition	%	-8.34
	8066295	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.87	CHEMBL3988	Homo sapiens	Inhibition	%	0.87
	8066431	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.61	CHEMBL3988	Homo sapiens	Inhibition	%	1.61
	8066597	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	6.38	CHEMBL3988	Homo sapiens	Inhibition	%	6.38
	8066821	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	10.37	CHEMBL3988	Homo sapiens	Inhibition	%	10.37
	8066945	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	52.14	CHEMBL3988	Homo sapiens	Inhibition	%	52.14
	8067344	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.8	CHEMBL3988	Homo sapiens	Inhibition	%	4.8
	8067465	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.31	CHEMBL3988	Homo sapiens	Inhibition	%	-0.31
	8067899	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-5.92	CHEMBL3988	Homo sapiens	Inhibition	%	-5.92
	8068034	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	9.67	CHEMBL3988	Homo sapiens	Inhibition	%	9.67
	8068422	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	6.35	CHEMBL3988	Homo sapiens	Inhibition	%	6.35
	8068547	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	76.88	CHEMBL3988	Homo sapiens	Inhibition	%	76.88
	8068771	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	4.24	CHEMBL3988	Homo sapiens	Inhibition	%	4.24
	8068945	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	9.4	CHEMBL3988	Homo sapiens	Inhibition	%	9.4
	8069070	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.14	CHEMBL3988	Homo sapiens	Inhibition	%	5.14
	8069294	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	11.68	CHEMBL3988	Homo sapiens	Inhibition	%	11.68
	8069365	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	45.27	CHEMBL3988	Homo sapiens	Inhibition	%	45.27
	8069589	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.14	CHEMBL3988	Homo sapiens	Inhibition	%	6.14
	8069750	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	8.39	CHEMBL3988	Homo sapiens	Inhibition	%	8.39
	8070100	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.26	CHEMBL3988	Homo sapiens	Inhibition	%	2.26
	8070272	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-2.82	CHEMBL3988	Homo sapiens	Inhibition	%	-2.82
	8070621	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	6.74	CHEMBL3988	Homo sapiens	Inhibition	%	6.74
	8070919	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	14.66	CHEMBL3988	Homo sapiens	Inhibition	%	14.66
	8071076	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	6.66	CHEMBL3988	Homo sapiens	Inhibition	%	6.66
	8071426	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.45	CHEMBL3988	Homo sapiens	Inhibition	%	3.45
	8071599	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	8.03	CHEMBL3988	Homo sapiens	Inhibition	%	8.03
	8071823	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	7.41	CHEMBL3988	Homo sapiens	Inhibition	%	7.41
	8071948	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.1	CHEMBL3988	Homo sapiens	Inhibition	%	4.1
	8072262	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.63	CHEMBL3988	Homo sapiens	Inhibition	%	1.63
	8072419	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	7.34	CHEMBL3988	Homo sapiens	Inhibition	%	7.34
	8072643	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.86	CHEMBL3988	Homo sapiens	Inhibition	%	8.86
	8072768	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.46	CHEMBL3988	Homo sapiens	Inhibition	%	4.46
	8073159	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.95	CHEMBL3988	Homo sapiens	Inhibition	%	2.95
	8073284	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	83.35	CHEMBL3988	Homo sapiens	Inhibition	%	83.35
	8073627	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.11	CHEMBL3988	Homo sapiens	Inhibition	%	-0.11
	8073860	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	14.23	CHEMBL3988	Homo sapiens	Inhibition	%	14.23
	8074236	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	11.16	CHEMBL3988	Homo sapiens	Inhibition	%	11.16
	8074366	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.87	CHEMBL3988	Homo sapiens	Inhibition	%	2.87
	8074747	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.89	CHEMBL3988	Homo sapiens	Inhibition	%	5.89
	8074874	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	86.1	CHEMBL3988	Homo sapiens	Inhibition	%	86.1
	8075098	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.21	CHEMBL3988	Homo sapiens	Inhibition	%	0.21
	8075209	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-5.42	CHEMBL3988	Homo sapiens	Inhibition	%	-5.42
	8075446	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-7.89	CHEMBL3988	Homo sapiens	Inhibition	%	-7.89
	8075811	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.74	CHEMBL3988	Homo sapiens	Inhibition	%	8.74
	8075953	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	4.19	CHEMBL3988	Homo sapiens	Inhibition	%	4.19
	8076177	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.27	CHEMBL3988	Homo sapiens	Inhibition	%	0.27
	8076325	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.14	CHEMBL3988	Homo sapiens	Inhibition	%	-0.14
	8076683	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.38	CHEMBL3988	Homo sapiens	Inhibition	%	0.38
	8076785	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.1	CHEMBL3988	Homo sapiens	Inhibition	%	1.1
	8077009	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-5.4	CHEMBL3988	Homo sapiens	Inhibition	%	-5.4
	8077032	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-5.06	CHEMBL3988	Homo sapiens	Inhibition	%	-5.06
	8077256	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.14	CHEMBL3988	Homo sapiens	Inhibition	%	-1.14
	8077384	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	7.75	CHEMBL3988	Homo sapiens	Inhibition	%	7.75
	8077759	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.47	CHEMBL3988	Homo sapiens	Inhibition	%	0.47
	8077902	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.63	CHEMBL3988	Homo sapiens	Inhibition	%	4.63
	8078265	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-6.46	CHEMBL3988	Homo sapiens	Inhibition	%	-6.46
	8078591	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.9	CHEMBL3988	Homo sapiens	Inhibition	%	-1.9
	8078841	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-4.76	CHEMBL3988	Homo sapiens	Inhibition	%	-4.76
	8078957	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.99	CHEMBL3988	Homo sapiens	Inhibition	%	6.99
	8079181	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.3	CHEMBL3988	Homo sapiens	Inhibition	%	4.3
	8079339	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.22	CHEMBL3988	Homo sapiens	Inhibition	%	-2.22
	8079481	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.61	CHEMBL3988	Homo sapiens	Inhibition	%	3.61
	8079705	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.58	CHEMBL3988	Homo sapiens	Inhibition	%	4.58
	8079844	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-5.56	CHEMBL3988	Homo sapiens	Inhibition	%	-5.56
	8080173	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-7.94	CHEMBL3988	Homo sapiens	Inhibition	%	-7.94
	8080425	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.11	CHEMBL3988	Homo sapiens	Inhibition	%	-1.11
	8080764	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.9	CHEMBL3988	Homo sapiens	Inhibition	%	5.9
	8080928	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.2	CHEMBL3988	Homo sapiens	Inhibition	%	-0.2
	8081287	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-1.51	CHEMBL3988	Homo sapiens	Inhibition	%	-1.51
	8081431	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.74	CHEMBL3988	Homo sapiens	Inhibition	%	6.74
	8081758	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.17	CHEMBL3988	Homo sapiens	Inhibition	%	1.17
	8082010	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.79	CHEMBL3988	Homo sapiens	Inhibition	%	1.79
	8082347	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	5.92	CHEMBL3988	Homo sapiens	Inhibition	%	5.92
	8082520	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-7.34	CHEMBL3988	Homo sapiens	Inhibition	%	-7.34
	8082867	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.02	CHEMBL3988	Homo sapiens	Inhibition	%	4.02
	8083023	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	12.93	CHEMBL3988	Homo sapiens	Inhibition	%	12.93
	8083247	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.78	CHEMBL3988	Homo sapiens	Inhibition	%	9.78
	8083346	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-8.81	CHEMBL3988	Homo sapiens	Inhibition	%	-8.81
	8083600	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.61	CHEMBL3988	Homo sapiens	Inhibition	%	-4.61
	8083824	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-3.51	CHEMBL3988	Homo sapiens	Inhibition	%	-3.51
	8083934	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.99	CHEMBL3988	Homo sapiens	Inhibition	%	5.99
	8084119	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-6.76	CHEMBL3988	Homo sapiens	Inhibition	%	-6.76
	8084343	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.83	CHEMBL3988	Homo sapiens	Inhibition	%	8.83
	8084461	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.68	CHEMBL3988	Homo sapiens	Inhibition	%	0.68
	8084846	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	18.22	CHEMBL3988	Homo sapiens	Inhibition	%	18.22
	8084944	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.83	CHEMBL3988	Homo sapiens	Inhibition	%	1.83
	8085168	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-7.46	CHEMBL3988	Homo sapiens	Inhibition	%	-7.46
	8085424	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.93	CHEMBL3988	Homo sapiens	Inhibition	%	6.93
	8085532	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.11	CHEMBL3988	Homo sapiens	Inhibition	%	7.11
	8085945	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	31.03	CHEMBL3988	Homo sapiens	Inhibition	%	31.03
	8086060	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.93	CHEMBL3988	Homo sapiens	Inhibition	%	6.93
	8086284	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.96	CHEMBL3988	Homo sapiens	Inhibition	%	2.96
	8086446	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.94	CHEMBL3988	Homo sapiens	Inhibition	%	7.94
	8086769	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.04	CHEMBL3988	Homo sapiens	Inhibition	%	5.04
	8086980	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	7.99	CHEMBL3988	Homo sapiens	Inhibition	%	7.99
	8087138	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	12.06	CHEMBL3988	Homo sapiens	Inhibition	%	12.06
	8087362	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	6.75	CHEMBL3988	Homo sapiens	Inhibition	%	6.75
	8087476	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	45.26	CHEMBL3988	Homo sapiens	Inhibition	%	45.26
	8087838	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.16	CHEMBL3988	Homo sapiens	Inhibition	%	6.16
	8087980	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	9.14	CHEMBL3988	Homo sapiens	Inhibition	%	9.14
	8088204	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	11.31	CHEMBL3988	Homo sapiens	Inhibition	%	11.31
	8088352	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.75	CHEMBL3988	Homo sapiens	Inhibition	%	1.75
	8088704	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.22	CHEMBL3988	Homo sapiens	Inhibition	%	6.22
	8088797	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.78	CHEMBL3988	Homo sapiens	Inhibition	%	7.78
	8089021	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	9.13	CHEMBL3988	Homo sapiens	Inhibition	%	9.13
	8089149	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.96	CHEMBL3988	Homo sapiens	Inhibition	%	3.96
	8089521	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	4.39	CHEMBL3988	Homo sapiens	Inhibition	%	4.39
	8089641	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	10.67	CHEMBL3988	Homo sapiens	Inhibition	%	10.67
	8090045	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.34	CHEMBL3988	Homo sapiens	Inhibition	%	5.34
	8090210	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.76	CHEMBL3988	Homo sapiens	Inhibition	%	3.76
	8090601	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.25	CHEMBL3988	Homo sapiens	Inhibition	%	5.25
	8090740	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	9.91	CHEMBL3988	Homo sapiens	Inhibition	%	9.91
	8091169	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.98	CHEMBL3988	Homo sapiens	Inhibition	%	9.98
	8091306	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	43.56	CHEMBL3988	Homo sapiens	Inhibition	%	43.56
	8091685	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	8.5	CHEMBL3988	Homo sapiens	Inhibition	%	8.5
	8091801	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.21	CHEMBL3988	Homo sapiens	Inhibition	%	7.21
	8092025	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	12.8	CHEMBL3988	Homo sapiens	Inhibition	%	12.8
	8092162	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.92	CHEMBL3988	Homo sapiens	Inhibition	%	4.92
	8092537	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.11	CHEMBL3988	Homo sapiens	Inhibition	%	8.11
	8092685	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.07	CHEMBL3988	Homo sapiens	Inhibition	%	4.07
	8093038	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	14.25	CHEMBL3988	Homo sapiens	Inhibition	%	14.25
	8093350	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.53	CHEMBL3988	Homo sapiens	Inhibition	%	8.53
	8093490	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.42	CHEMBL3988	Homo sapiens	Inhibition	%	9.42
	8093853	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.99	CHEMBL3988	Homo sapiens	Inhibition	%	10.99
	8093973	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.58	CHEMBL3988	Homo sapiens	Inhibition	%	5.58
	8094197	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	9.33	CHEMBL3988	Homo sapiens	Inhibition	%	9.33
	8094377	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.64	CHEMBL3988	Homo sapiens	Inhibition	%	1.64
	8094552	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.41	CHEMBL3988	Homo sapiens	Inhibition	%	4.41
	8094776	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.96	CHEMBL3988	Homo sapiens	Inhibition	%	4.96
	8094932	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	8.81	CHEMBL3988	Homo sapiens	Inhibition	%	8.81
	8095072	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	9.59	CHEMBL3988	Homo sapiens	Inhibition	%	9.59
	8095296	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	59.75	CHEMBL3988	Homo sapiens	Inhibition	%	59.75
	8095499	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	11.46	CHEMBL3988	Homo sapiens	Inhibition	%	11.46
	8095640	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.85	CHEMBL3988	Homo sapiens	Inhibition	%	5.85
	8095864	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	10.76	CHEMBL3988	Homo sapiens	Inhibition	%	10.76
	8096012	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.83	CHEMBL3988	Homo sapiens	Inhibition	%	4.83
	8096353	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.26	CHEMBL3988	Homo sapiens	Inhibition	%	8.26
	8096492	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.9	CHEMBL3988	Homo sapiens	Inhibition	%	5.9
	8096872	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	10.37	CHEMBL3988	Homo sapiens	Inhibition	%	10.37
	8097019	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.88	CHEMBL3988	Homo sapiens	Inhibition	%	-0.88
	8097243	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.82	CHEMBL3988	Homo sapiens	Inhibition	%	2.82
	8097330	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	9.66	CHEMBL3988	Homo sapiens	Inhibition	%	9.66
	8097550	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	13.34	CHEMBL3988	Homo sapiens	Inhibition	%	13.34
	8097700	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-5.47	CHEMBL3988	Homo sapiens	Inhibition	%	-5.47
	8097924	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	6.31	CHEMBL3988	Homo sapiens	Inhibition	%	6.31
	8098057	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	4.23	CHEMBL3988	Homo sapiens	Inhibition	%	4.23
	8098401	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.79	CHEMBL3988	Homo sapiens	Inhibition	%	-0.79
	8098581	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.95	CHEMBL3988	Homo sapiens	Inhibition	%	3.95
	8098990	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.43	CHEMBL3988	Homo sapiens	Inhibition	%	6.43
	8099134	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.01	CHEMBL3988	Homo sapiens	Inhibition	%	8.01
	8099500	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.55	CHEMBL3988	Homo sapiens	Inhibition	%	5.55
	8099694	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.96	CHEMBL3988	Homo sapiens	Inhibition	%	5.96
	8100065	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.44	CHEMBL3988	Homo sapiens	Inhibition	%	7.44
	8100211	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.82	CHEMBL3988	Homo sapiens	Inhibition	%	6.82
	8100551	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	12.22	CHEMBL3988	Homo sapiens	Inhibition	%	12.22
	8100691	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.8	CHEMBL3988	Homo sapiens	Inhibition	%	2.8
	8100915	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.82	CHEMBL3988	Homo sapiens	Inhibition	%	3.82
	8101075	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.67	CHEMBL3988	Homo sapiens	Inhibition	%	6.67
	8101441	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-7.25	CHEMBL3988	Homo sapiens	Inhibition	%	-7.25
	8101626	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.03	CHEMBL3988	Homo sapiens	Inhibition	%	6.03
	8101879	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	8.17	CHEMBL3988	Homo sapiens	Inhibition	%	8.17
	8102258	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	31.02	CHEMBL3988	Homo sapiens	Inhibition	%	31.02
	8102389	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	5.32	CHEMBL3988	Homo sapiens	Inhibition	%	5.32
	8102733	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.39	CHEMBL3988	Homo sapiens	Inhibition	%	3.39
	8102911	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.05	CHEMBL3988	Homo sapiens	Inhibition	%	0.05
	8103135	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.86	CHEMBL3988	Homo sapiens	Inhibition	%	2.86
	8103331	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.06	CHEMBL3988	Homo sapiens	Inhibition	%	5.06
	8103469	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.86	CHEMBL3988	Homo sapiens	Inhibition	%	5.86
	8103693	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.65	CHEMBL3988	Homo sapiens	Inhibition	%	5.65
	8103843	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	10.56	CHEMBL3988	Homo sapiens	Inhibition	%	10.56
	8104028	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	15.63	CHEMBL3988	Homo sapiens	Inhibition	%	15.63
	8104400	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	11.28	CHEMBL3988	Homo sapiens	Inhibition	%	11.28
	8104546	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.13	CHEMBL3988	Homo sapiens	Inhibition	%	5.13
	8104770	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	10.81	CHEMBL3988	Homo sapiens	Inhibition	%	10.81
	8104884	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	7.21	CHEMBL3988	Homo sapiens	Inhibition	%	7.21
	8105248	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.62	CHEMBL3988	Homo sapiens	Inhibition	%	-0.62
	8105414	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.05	CHEMBL3988	Homo sapiens	Inhibition	%	8.05
	8105776	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.47	CHEMBL3988	Homo sapiens	Inhibition	%	1.47
	8106056	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	8.19	CHEMBL3988	Homo sapiens	Inhibition	%	8.19
	8106221	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	30.5	CHEMBL3988	Homo sapiens	Inhibition	%	30.5
	8106445	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.0	CHEMBL3988	Homo sapiens	Inhibition	%	7.0
	8106601	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	81.06	CHEMBL3988	Homo sapiens	Inhibition	%	81.06
	8106730	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	9.54	CHEMBL3988	Homo sapiens	Inhibition	%	9.54
	8106954	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	13.75	CHEMBL3988	Homo sapiens	Inhibition	%	13.75
	8107075	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.23	CHEMBL3988	Homo sapiens	Inhibition	%	0.23
	8107471	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.57	CHEMBL3988	Homo sapiens	Inhibition	%	4.57
	8107672	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.87	CHEMBL3988	Homo sapiens	Inhibition	%	4.87
	8108031	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	29.08	CHEMBL3988	Homo sapiens	Inhibition	%	29.08
	8108189	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.55	CHEMBL3988	Homo sapiens	Inhibition	%	7.55
	8108364	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	22.32	CHEMBL3988	Homo sapiens	Inhibition	%	22.32
	8108588	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	62.9	CHEMBL3988	Homo sapiens	Inhibition	%	62.9
	8108735	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.9	CHEMBL3988	Homo sapiens	Inhibition	%	8.9
	8109101	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.2	CHEMBL3988	Homo sapiens	Inhibition	%	2.2
	8109215	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	9.65	CHEMBL3988	Homo sapiens	Inhibition	%	9.65
	8109439	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.4	CHEMBL3988	Homo sapiens	Inhibition	%	5.4
	8109569	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.11	CHEMBL3988	Homo sapiens	Inhibition	%	2.11
	8109740	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.06	CHEMBL3988	Homo sapiens	Inhibition	%	7.06
	8109964	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	9.83	CHEMBL3988	Homo sapiens	Inhibition	%	9.83
	8110096	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.98	CHEMBL3988	Homo sapiens	Inhibition	%	8.98
	8110375	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.69	CHEMBL3988	Homo sapiens	Inhibition	%	0.69
	8110765	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	9.0	CHEMBL3988	Homo sapiens	Inhibition	%	9.0
	8110923	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.41	CHEMBL3988	Homo sapiens	Inhibition	%	-3.41
	8111270	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	52.27	CHEMBL3988	Homo sapiens	Inhibition	%	52.27
	8111397	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.4	CHEMBL3988	Homo sapiens	Inhibition	%	3.4
	8111621	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.1	CHEMBL3988	Homo sapiens	Inhibition	%	-0.1
	8111787	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	8.16	CHEMBL3988	Homo sapiens	Inhibition	%	8.16
	8111992	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.68	CHEMBL3988	Homo sapiens	Inhibition	%	5.68
	8112353	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.69	CHEMBL3988	Homo sapiens	Inhibition	%	3.69
	8112521	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	13.18	CHEMBL3988	Homo sapiens	Inhibition	%	13.18
	8112917	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.33	CHEMBL3988	Homo sapiens	Inhibition	%	4.33
	8113069	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	11.57	CHEMBL3988	Homo sapiens	Inhibition	%	11.57
	8113429	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.8	CHEMBL3988	Homo sapiens	Inhibition	%	5.8
	8113777	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	8.41	CHEMBL3988	Homo sapiens	Inhibition	%	8.41
	8113893	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-8.27	CHEMBL3988	Homo sapiens	Inhibition	%	-8.27
	8114293	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.4	CHEMBL3988	Homo sapiens	Inhibition	%	6.4
	8114425	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	13.69	CHEMBL3988	Homo sapiens	Inhibition	%	13.69
	8114649	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	7.43	CHEMBL3988	Homo sapiens	Inhibition	%	7.43
	8114701	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	8.35	CHEMBL3988	Homo sapiens	Inhibition	%	8.35
	8114925	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.57	CHEMBL3988	Homo sapiens	Inhibition	%	3.57
	8115091	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	47.08	CHEMBL3988	Homo sapiens	Inhibition	%	47.08
	8115256	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.82	CHEMBL3988	Homo sapiens	Inhibition	%	3.82
	8115600	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	72.35	CHEMBL3988	Homo sapiens	Inhibition	%	72.35
	8115957	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.58	CHEMBL3988	Homo sapiens	Inhibition	%	2.58
	8116116	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.06	CHEMBL3988	Homo sapiens	Inhibition	%	-0.06
	8116319	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.88	CHEMBL3988	Homo sapiens	Inhibition	%	5.88
	8116543	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.06	CHEMBL3988	Homo sapiens	Inhibition	%	4.06
	8116677	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	6.36	CHEMBL3988	Homo sapiens	Inhibition	%	6.36
	8116849	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	54.92	CHEMBL3988	Homo sapiens	Inhibition	%	54.92
	8117073	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	92.05	CHEMBL3988	Homo sapiens	Inhibition	%	92.05
	8117244	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	6.25	CHEMBL3988	Homo sapiens	Inhibition	%	6.25
	8117402	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.0	CHEMBL3988	Homo sapiens	Inhibition	%	4.0
	8117626	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.24	CHEMBL3988	Homo sapiens	Inhibition	%	8.24
	8117756	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.26	CHEMBL3988	Homo sapiens	Inhibition	%	1.26
	8118118	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.95	CHEMBL3988	Homo sapiens	Inhibition	%	6.95
	8118234	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-5.77	CHEMBL3988	Homo sapiens	Inhibition	%	-5.77
	8118458	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	8.42	CHEMBL3988	Homo sapiens	Inhibition	%	8.42
	8118630	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	8.61	CHEMBL3988	Homo sapiens	Inhibition	%	8.61
	8118990	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	9.74	CHEMBL3988	Homo sapiens	Inhibition	%	9.74
	8119261	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	6.35	CHEMBL3988	Homo sapiens	Inhibition	%	6.35
	8119420	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	77.18	CHEMBL3988	Homo sapiens	Inhibition	%	77.18
	8119587	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.13	CHEMBL3988	Homo sapiens	Inhibition	%	1.13
	8119811	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	5.16	CHEMBL3988	Homo sapiens	Inhibition	%	5.16
	8119930	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	11.67	CHEMBL3988	Homo sapiens	Inhibition	%	11.67
	8120293	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.21	CHEMBL3988	Homo sapiens	Inhibition	%	1.21
	8120453	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	10.3	CHEMBL3988	Homo sapiens	Inhibition	%	10.3
	8120677	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.59	CHEMBL3988	Homo sapiens	Inhibition	%	-0.59
	8120878	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	6.59	CHEMBL3988	Homo sapiens	Inhibition	%	6.59
	8121006	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.01	CHEMBL3988	Homo sapiens	Inhibition	%	3.01
	8121402	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.73	CHEMBL3988	Homo sapiens	Inhibition	%	3.73
	8121569	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.79	CHEMBL3988	Homo sapiens	Inhibition	%	3.79
	8121956	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.29	CHEMBL3988	Homo sapiens	Inhibition	%	6.29
	8122077	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.95	CHEMBL3988	Homo sapiens	Inhibition	%	9.95
	8122301	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	14.39	CHEMBL3988	Homo sapiens	Inhibition	%	14.39
	8122439	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	9.68	CHEMBL3988	Homo sapiens	Inhibition	%	9.68
	8122783	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	10.13	CHEMBL3988	Homo sapiens	Inhibition	%	10.13
	8122950	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.86	CHEMBL3988	Homo sapiens	Inhibition	%	7.86
	8123316	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	11.31	CHEMBL3988	Homo sapiens	Inhibition	%	11.31
	8123594	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-1.05	CHEMBL3988	Homo sapiens	Inhibition	%	-1.05
	8123744	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	10.22	CHEMBL3988	Homo sapiens	Inhibition	%	10.22
	8124135	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.18	CHEMBL3988	Homo sapiens	Inhibition	%	3.18
	8124254	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	20.98	CHEMBL3988	Homo sapiens	Inhibition	%	20.98
	8124478	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	9.73	CHEMBL3988	Homo sapiens	Inhibition	%	9.73
	8124617	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.57	CHEMBL3988	Homo sapiens	Inhibition	%	3.57
	8125006	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.79	CHEMBL3988	Homo sapiens	Inhibition	%	1.79
	8125207	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	9.41	CHEMBL3988	Homo sapiens	Inhibition	%	9.41
	8125337	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	5.06	CHEMBL3988	Homo sapiens	Inhibition	%	5.06
	8125561	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.83	CHEMBL3988	Homo sapiens	Inhibition	%	0.83
	8125729	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	5.5	CHEMBL3988	Homo sapiens	Inhibition	%	5.5
	8125893	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.47	CHEMBL3988	Homo sapiens	Inhibition	%	5.47
	8126117	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.7	CHEMBL3988	Homo sapiens	Inhibition	%	-1.7
	8126281	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.89	CHEMBL3988	Homo sapiens	Inhibition	%	9.89
	8126620	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	77.88	CHEMBL3988	Homo sapiens	Inhibition	%	77.88
	8126756	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	8.05	CHEMBL3988	Homo sapiens	Inhibition	%	8.05
	8127102	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.9	CHEMBL3988	Homo sapiens	Inhibition	%	6.9
	8127269	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	11.97	CHEMBL3988	Homo sapiens	Inhibition	%	11.97
	8127493	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	11.34	CHEMBL3988	Homo sapiens	Inhibition	%	11.34
	8127635	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	23.34	CHEMBL3988	Homo sapiens	Inhibition	%	23.34
	8127923	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.4	CHEMBL3988	Homo sapiens	Inhibition	%	5.4
	8128075	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	17.11	CHEMBL3988	Homo sapiens	Inhibition	%	17.11
	8128299	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.99	CHEMBL3988	Homo sapiens	Inhibition	%	8.99
	8128466	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	25.6	CHEMBL3988	Homo sapiens	Inhibition	%	25.6
	8128809	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	36.59	CHEMBL3988	Homo sapiens	Inhibition	%	36.59
	8128946	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.6	CHEMBL3988	Homo sapiens	Inhibition	%	0.6
	8129341	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.28	CHEMBL3988	Homo sapiens	Inhibition	%	-1.28
	8129530	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.55	CHEMBL3988	Homo sapiens	Inhibition	%	10.55
	8129893	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.33	CHEMBL3988	Homo sapiens	Inhibition	%	2.33
	8130054	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.82	CHEMBL3988	Homo sapiens	Inhibition	%	5.82
	8130450	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.26	CHEMBL3988	Homo sapiens	Inhibition	%	-0.26
	8130610	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	6.79	CHEMBL3988	Homo sapiens	Inhibition	%	6.79
	8130950	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.19	CHEMBL3988	Homo sapiens	Inhibition	%	7.19
	8131089	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	22.41	CHEMBL3988	Homo sapiens	Inhibition	%	22.41
	8131313	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.94	CHEMBL3988	Homo sapiens	Inhibition	%	7.94
	8131433	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.87	CHEMBL3988	Homo sapiens	Inhibition	%	7.87
	8131824	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	33.52	CHEMBL3988	Homo sapiens	Inhibition	%	33.52
	8131965	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	46.81	CHEMBL3988	Homo sapiens	Inhibition	%	46.81
	8132251	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.74	CHEMBL3988	Homo sapiens	Inhibition	%	3.74
	8132622	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	18.64	CHEMBL3988	Homo sapiens	Inhibition	%	18.64
	8132790	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.99	CHEMBL3988	Homo sapiens	Inhibition	%	3.99
	8133135	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.02	CHEMBL3988	Homo sapiens	Inhibition	%	5.02
	8133273	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.76	CHEMBL3988	Homo sapiens	Inhibition	%	1.76
	8133497	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.3	CHEMBL3988	Homo sapiens	Inhibition	%	5.3
	8133669	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.81	CHEMBL3988	Homo sapiens	Inhibition	%	0.81
	8133849	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.53	CHEMBL3988	Homo sapiens	Inhibition	%	5.53
	8134073	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	22.89	CHEMBL3988	Homo sapiens	Inhibition	%	22.89
	8134221	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.85	CHEMBL3988	Homo sapiens	Inhibition	%	-2.85
	8134381	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	7.58	CHEMBL3988	Homo sapiens	Inhibition	%	7.58
	8134605	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.05	CHEMBL3988	Homo sapiens	Inhibition	%	5.05
	8134789	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-6.81	CHEMBL3988	Homo sapiens	Inhibition	%	-6.81
	8134949	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	15.21	CHEMBL3988	Homo sapiens	Inhibition	%	15.21
	8135173	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	6.16	CHEMBL3988	Homo sapiens	Inhibition	%	6.16
	8135288	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	10.08	CHEMBL3988	Homo sapiens	Inhibition	%	10.08
	8135653	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	11.45	CHEMBL3988	Homo sapiens	Inhibition	%	11.45
	8135774	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	6.49	CHEMBL3988	Homo sapiens	Inhibition	%	6.49
	8135998	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	8.07	CHEMBL3988	Homo sapiens	Inhibition	%	8.07
	8136166	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.9	CHEMBL3988	Homo sapiens	Inhibition	%	6.9
	8136310	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	78.27	CHEMBL3988	Homo sapiens	Inhibition	%	78.27
	8136534	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	11.29	CHEMBL3988	Homo sapiens	Inhibition	%	11.29
	8136600	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.77	CHEMBL3988	Homo sapiens	Inhibition	%	3.77
	8136824	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.31	CHEMBL3988	Homo sapiens	Inhibition	%	-1.31
	8136959	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.53	CHEMBL3988	Homo sapiens	Inhibition	%	6.53
	8137122	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	14.99	CHEMBL3988	Homo sapiens	Inhibition	%	14.99
	8137346	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	4.65	CHEMBL3988	Homo sapiens	Inhibition	%	4.65
	8137466	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	12.97	CHEMBL3988	Homo sapiens	Inhibition	%	12.97
	8137838	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	7.67	CHEMBL3988	Homo sapiens	Inhibition	%	7.67
	8138004	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-3.04	CHEMBL3988	Homo sapiens	Inhibition	%	-3.04
	8138407	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.66	CHEMBL3988	Homo sapiens	Inhibition	%	0.66
	8138555	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.4	CHEMBL3988	Homo sapiens	Inhibition	%	1.4
	8138937	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	6.13	CHEMBL3988	Homo sapiens	Inhibition	%	6.13
	8139122	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.53	CHEMBL3988	Homo sapiens	Inhibition	%	-2.53
	8139505	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	17.27	CHEMBL3988	Homo sapiens	Inhibition	%	17.27
	8139619	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.33	CHEMBL3988	Homo sapiens	Inhibition	%	6.33
	8139984	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.3	CHEMBL3988	Homo sapiens	Inhibition	%	7.3
	8140331	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.09	CHEMBL3988	Homo sapiens	Inhibition	%	7.09
	8140490	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	9.69	CHEMBL3988	Homo sapiens	Inhibition	%	9.69
	8140857	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	15.37	CHEMBL3988	Homo sapiens	Inhibition	%	15.37
	8141159	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.39	CHEMBL3988	Homo sapiens	Inhibition	%	3.39
	8141289	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.28	CHEMBL3988	Homo sapiens	Inhibition	%	4.28
	8141673	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	17.41	CHEMBL3988	Homo sapiens	Inhibition	%	17.41
	8141792	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	25.49	CHEMBL3988	Homo sapiens	Inhibition	%	25.49
	8142016	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	80.91	CHEMBL3988	Homo sapiens	Inhibition	%	80.91
	8142177	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.61	CHEMBL3988	Homo sapiens	Inhibition	%	0.61
	8142345	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.99	CHEMBL3988	Homo sapiens	Inhibition	%	-0.99
	8142569	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-6.91	CHEMBL3988	Homo sapiens	Inhibition	%	-6.91
	8142745	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	7.07	CHEMBL3988	Homo sapiens	Inhibition	%	7.07
	8142894	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.17	CHEMBL3988	Homo sapiens	Inhibition	%	-6.17
	8143118	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.72	CHEMBL3988	Homo sapiens	Inhibition	%	-6.72
	8143273	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.49	CHEMBL3988	Homo sapiens	Inhibition	%	6.49
	8143460	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.31	CHEMBL3988	Homo sapiens	Inhibition	%	7.31
	8143843	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.59	CHEMBL3988	Homo sapiens	Inhibition	%	8.59
	8143957	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.84	CHEMBL3988	Homo sapiens	Inhibition	%	7.84
	8144181	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.0	CHEMBL3988	Homo sapiens	Inhibition	%	7.0
	8144320	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	11.56	CHEMBL3988	Homo sapiens	Inhibition	%	11.56
	8144674	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.32	CHEMBL3988	Homo sapiens	Inhibition	%	8.32
	8144827	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.15	CHEMBL3988	Homo sapiens	Inhibition	%	5.15
	8145188	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.63	CHEMBL3988	Homo sapiens	Inhibition	%	5.63
	8145501	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	6.36	CHEMBL3988	Homo sapiens	Inhibition	%	6.36
	8145625	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.1	CHEMBL3988	Homo sapiens	Inhibition	%	6.1
	8145849	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.98	CHEMBL3988	Homo sapiens	Inhibition	%	7.98
	8146010	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.57	CHEMBL3988	Homo sapiens	Inhibition	%	10.57
	8146354	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	49.45	CHEMBL3988	Homo sapiens	Inhibition	%	49.45
	8146514	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	13.77	CHEMBL3988	Homo sapiens	Inhibition	%	13.77
	8146905	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-4.57	CHEMBL3988	Homo sapiens	Inhibition	%	-4.57
	8147074	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.03	CHEMBL3988	Homo sapiens	Inhibition	%	4.03
	8147440	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	5.08	CHEMBL3988	Homo sapiens	Inhibition	%	5.08
	8147593	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	8.04	CHEMBL3988	Homo sapiens	Inhibition	%	8.04
	8147780	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.77	CHEMBL3988	Homo sapiens	Inhibition	%	9.77
	8148004	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.35	CHEMBL3988	Homo sapiens	Inhibition	%	6.35
	8148162	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	33.92	CHEMBL3988	Homo sapiens	Inhibition	%	33.92
	8148500	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	10.87	CHEMBL3988	Homo sapiens	Inhibition	%	10.87
	8148639	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.05	CHEMBL3988	Homo sapiens	Inhibition	%	7.05
	8148863	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	9.82	CHEMBL3988	Homo sapiens	Inhibition	%	9.82
	8149001	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.5	CHEMBL3988	Homo sapiens	Inhibition	%	8.5
	8149160	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	6.55	CHEMBL3988	Homo sapiens	Inhibition	%	6.55
	8149384	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.75	CHEMBL3988	Homo sapiens	Inhibition	%	1.75
	8149518	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	13.34	CHEMBL3988	Homo sapiens	Inhibition	%	13.34
	8149840	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	17.66	CHEMBL3988	Homo sapiens	Inhibition	%	17.66
	8150189	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	36.29	CHEMBL3988	Homo sapiens	Inhibition	%	36.29
	8150349	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	33.79	CHEMBL3988	Homo sapiens	Inhibition	%	33.79
	8150693	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	81.62	CHEMBL3988	Homo sapiens	Inhibition	%	81.62
	8150858	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.13	CHEMBL3988	Homo sapiens	Inhibition	%	0.13
	8151245	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1	Outside typical range	CHEMBL495902	=	Inhibition	%	-10.57	CHEMBL3988	Homo sapiens	Inhibition	%	-10.57
	8151422	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	9.16	CHEMBL3988	Homo sapiens	Inhibition	%	9.16
	8151784	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-4.97	CHEMBL3988	Homo sapiens	Inhibition	%	-4.97
	8151938	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.95	CHEMBL3988	Homo sapiens	Inhibition	%	5.95
	8152162	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	8.87	CHEMBL3988	Homo sapiens	Inhibition	%	8.87
	8152350	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	12.15	CHEMBL3988	Homo sapiens	Inhibition	%	12.15
	8152508	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.56	CHEMBL3988	Homo sapiens	Inhibition	%	7.56
	8152846	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	11.79	CHEMBL3988	Homo sapiens	Inhibition	%	11.79
	8153209	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.95	CHEMBL3988	Homo sapiens	Inhibition	%	4.95
	8153346	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	10.97	CHEMBL3988	Homo sapiens	Inhibition	%	10.97
	8153727	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	5.59	CHEMBL3988	Homo sapiens	Inhibition	%	5.59
	8153860	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.32	CHEMBL3988	Homo sapiens	Inhibition	%	7.32
	8154084	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	10.05	CHEMBL3988	Homo sapiens	Inhibition	%	10.05
	8154181	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	61.39	CHEMBL3988	Homo sapiens	Inhibition	%	61.39
	8154531	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	86.9	CHEMBL3988	Homo sapiens	Inhibition	%	86.9
	8154690	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	5.81	CHEMBL3988	Homo sapiens	Inhibition	%	5.81
	8154914	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	6.8	CHEMBL3988	Homo sapiens	Inhibition	%	6.8
	8155034	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	6.45	CHEMBL3988	Homo sapiens	Inhibition	%	6.45
	8155210	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.13	CHEMBL3988	Homo sapiens	Inhibition	%	4.13
	8155434	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.89	CHEMBL3988	Homo sapiens	Inhibition	%	2.89
	8155595	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-8.91	CHEMBL3988	Homo sapiens	Inhibition	%	-8.91
	8155773	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.8	CHEMBL3988	Homo sapiens	Inhibition	%	4.8
	8155997	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	8.02	CHEMBL3988	Homo sapiens	Inhibition	%	8.02
	8156135	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.67	CHEMBL3988	Homo sapiens	Inhibition	%	6.67
	8156347	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-0.84	CHEMBL3988	Homo sapiens	Inhibition	%	-0.84
	8156571	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.88	CHEMBL3988	Homo sapiens	Inhibition	%	8.88
	8156721	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	16.94	CHEMBL3988	Homo sapiens	Inhibition	%	16.94
	8156864	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.23	CHEMBL3988	Homo sapiens	Inhibition	%	7.23
	8157088	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.04	CHEMBL3988	Homo sapiens	Inhibition	%	12.04
	8157208	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.51	CHEMBL3988	Homo sapiens	Inhibition	%	5.51
	8157573	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	22.44	CHEMBL3988	Homo sapiens	Inhibition	%	22.44
	8157703	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	64.17	CHEMBL3988	Homo sapiens	Inhibition	%	64.17
	8157927	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	8.15	CHEMBL3988	Homo sapiens	Inhibition	%	8.15
	8158088	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.14	CHEMBL3988	Homo sapiens	Inhibition	%	-0.14
	8158338	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	17.55	CHEMBL3988	Homo sapiens	Inhibition	%	17.55
	8158720	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.58	CHEMBL3988	Homo sapiens	Inhibition	%	5.58
	8158889	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.23	CHEMBL3988	Homo sapiens	Inhibition	%	5.23
	8159248	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	10.42	CHEMBL3988	Homo sapiens	Inhibition	%	10.42
	8159368	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.71	CHEMBL3988	Homo sapiens	Inhibition	%	6.71
	8159592	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.26	CHEMBL3988	Homo sapiens	Inhibition	%	6.26
	8159723	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.86	CHEMBL3988	Homo sapiens	Inhibition	%	7.86
	8160088	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.75	CHEMBL3988	Homo sapiens	Inhibition	%	2.75
	8160225	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.58	CHEMBL3988	Homo sapiens	Inhibition	%	7.58
	8160599	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-4.75	CHEMBL3988	Homo sapiens	Inhibition	%	-4.75
	8160893	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	20.53	CHEMBL3988	Homo sapiens	Inhibition	%	20.53
	8161043	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	8.57	CHEMBL3988	Homo sapiens	Inhibition	%	8.57
	8161410	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	11.99	CHEMBL3988	Homo sapiens	Inhibition	%	11.99
	8161535	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.67	CHEMBL3988	Homo sapiens	Inhibition	%	5.67
	8161759	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.56	CHEMBL3988	Homo sapiens	Inhibition	%	5.56
	8161897	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	56.11	CHEMBL3988	Homo sapiens	Inhibition	%	56.11
	8162251	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.39	CHEMBL3988	Homo sapiens	Inhibition	%	13.39
	8162411	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	6.02	CHEMBL3988	Homo sapiens	Inhibition	%	6.02
	8162664	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	9.5	CHEMBL3988	Homo sapiens	Inhibition	%	9.5
	8163036	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	11.31	CHEMBL3988	Homo sapiens	Inhibition	%	11.31
	8163205	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.94	CHEMBL3988	Homo sapiens	Inhibition	%	3.94
	8163563	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	12.29	CHEMBL3988	Homo sapiens	Inhibition	%	12.29
	8163910	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	8.11	CHEMBL3988	Homo sapiens	Inhibition	%	8.11
	8164044	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.97	CHEMBL3988	Homo sapiens	Inhibition	%	8.97
	8164408	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.35	CHEMBL3988	Homo sapiens	Inhibition	%	0.35
	8164563	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	13.07	CHEMBL3988	Homo sapiens	Inhibition	%	13.07
	8164931	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	14.48	CHEMBL3988	Homo sapiens	Inhibition	%	14.48
	8165225	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.88	CHEMBL3988	Homo sapiens	Inhibition	%	7.88
	8165366	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	19.61	CHEMBL3988	Homo sapiens	Inhibition	%	19.61
	8165590	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	8.3	CHEMBL3988	Homo sapiens	Inhibition	%	8.3
	8165733	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	28.18	CHEMBL3988	Homo sapiens	Inhibition	%	28.18
	8166083	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.36	CHEMBL3988	Homo sapiens	Inhibition	%	2.36
	8166221	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.18	CHEMBL3988	Homo sapiens	Inhibition	%	8.18
	8166575	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	11.66	CHEMBL3988	Homo sapiens	Inhibition	%	11.66
	8166900	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	75.18	CHEMBL3988	Homo sapiens	Inhibition	%	75.18
	8166988	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	10.02	CHEMBL3988	Homo sapiens	Inhibition	%	10.02
	8167212	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.53	CHEMBL3988	Homo sapiens	Inhibition	%	7.53
	8167353	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	33.67	CHEMBL3988	Homo sapiens	Inhibition	%	33.67
	8167517	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.92	CHEMBL3988	Homo sapiens	Inhibition	%	6.92
	8167741	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.64	CHEMBL3988	Homo sapiens	Inhibition	%	2.64
	8167874	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	11.31	CHEMBL3988	Homo sapiens	Inhibition	%	11.31
	8168222	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.19	CHEMBL3988	Homo sapiens	Inhibition	%	4.19
	8168363	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.53	CHEMBL3988	Homo sapiens	Inhibition	%	4.53
	8168587	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	11.79	CHEMBL3988	Homo sapiens	Inhibition	%	11.79
	8168723	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.89	CHEMBL3988	Homo sapiens	Inhibition	%	-1.89
	8168887	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	13.03	CHEMBL3988	Homo sapiens	Inhibition	%	13.03
	8169111	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	43.79	CHEMBL3988	Homo sapiens	Inhibition	%	43.79
	8169253	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.41	CHEMBL3988	Homo sapiens	Inhibition	%	5.41
	8169557	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.89	CHEMBL3988	Homo sapiens	Inhibition	%	7.89
	8169915	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	11.99	CHEMBL3988	Homo sapiens	Inhibition	%	11.99
	8170060	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	8.44	CHEMBL3988	Homo sapiens	Inhibition	%	8.44
	8170409	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	6.06	CHEMBL3988	Homo sapiens	Inhibition	%	6.06
	8170549	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.0	CHEMBL3988	Homo sapiens	Inhibition	%	10.0
	8170773	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.43	CHEMBL3988	Homo sapiens	Inhibition	%	7.43
	8170908	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	32.86	CHEMBL3988	Homo sapiens	Inhibition	%	32.86
	8171105	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	25.93	CHEMBL3988	Homo sapiens	Inhibition	%	25.93
	8171329	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	41.42	CHEMBL3988	Homo sapiens	Inhibition	%	41.42
	8171546	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.73	CHEMBL3988	Homo sapiens	Inhibition	%	7.73
	8171687	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.86	CHEMBL3988	Homo sapiens	Inhibition	%	7.86
	8172064	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.81	CHEMBL3988	Homo sapiens	Inhibition	%	4.81
	8172196	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	14.99	CHEMBL3988	Homo sapiens	Inhibition	%	14.99
	8172420	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	12.93	CHEMBL3988	Homo sapiens	Inhibition	%	12.93
	8172548	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.52	CHEMBL3988	Homo sapiens	Inhibition	%	4.52
	8172914	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	29.71	CHEMBL3988	Homo sapiens	Inhibition	%	29.71
	8173050	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-5.25	CHEMBL3988	Homo sapiens	Inhibition	%	-5.25
	8173439	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	11.11	CHEMBL3988	Homo sapiens	Inhibition	%	11.11
	8173580	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.08	CHEMBL3988	Homo sapiens	Inhibition	%	1.08
	8173804	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.36	CHEMBL3988	Homo sapiens	Inhibition	%	3.36
	8173891	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	10.66	CHEMBL3988	Homo sapiens	Inhibition	%	10.66
	8174247	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	19.03	CHEMBL3988	Homo sapiens	Inhibition	%	19.03
	8174395	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	44.49	CHEMBL3988	Homo sapiens	Inhibition	%	44.49
	8174619	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.89	CHEMBL3988	Homo sapiens	Inhibition	%	4.89
	8174741	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.18	CHEMBL3988	Homo sapiens	Inhibition	%	7.18
	8175108	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.66	CHEMBL3988	Homo sapiens	Inhibition	%	7.66
	8175244	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	8.08	CHEMBL3988	Homo sapiens	Inhibition	%	8.08
	8175500	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.98	CHEMBL3988	Homo sapiens	Inhibition	%	4.98
	8175724	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.34	CHEMBL3988	Homo sapiens	Inhibition	%	12.34
	8175887	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	12.2	CHEMBL3988	Homo sapiens	Inhibition	%	12.2
	8176040	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.49	CHEMBL3988	Homo sapiens	Inhibition	%	6.49
	8176264	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.54	CHEMBL3988	Homo sapiens	Inhibition	%	9.54
	8176413	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.57	CHEMBL3988	Homo sapiens	Inhibition	%	2.57
	8176769	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.31	CHEMBL3988	Homo sapiens	Inhibition	%	16.31
	8176899	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.18	CHEMBL3988	Homo sapiens	Inhibition	%	0.18
	8177265	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	37.35	CHEMBL3988	Homo sapiens	Inhibition	%	37.35
	8177403	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-5.49	CHEMBL3988	Homo sapiens	Inhibition	%	-5.49
	8177627	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.06	CHEMBL3988	Homo sapiens	Inhibition	%	10.06
	8177791	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	35.45	CHEMBL3988	Homo sapiens	Inhibition	%	35.45
	8178155	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.16	CHEMBL3988	Homo sapiens	Inhibition	%	5.16
	8178243	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	16.29	CHEMBL3988	Homo sapiens	Inhibition	%	16.29
	8178467	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.54	CHEMBL3988	Homo sapiens	Inhibition	%	7.54
	8178594	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	66.57	CHEMBL3988	Homo sapiens	Inhibition	%	66.57
	8178967	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.51	CHEMBL3988	Homo sapiens	Inhibition	%	-0.51
	8179090	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	8.98	CHEMBL3988	Homo sapiens	Inhibition	%	8.98
	8179458	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	8.7	CHEMBL3988	Homo sapiens	Inhibition	%	8.7
	8179595	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	10.35	CHEMBL3988	Homo sapiens	Inhibition	%	10.35
	8179819	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.97	CHEMBL3988	Homo sapiens	Inhibition	%	5.97
	8180076	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.03	CHEMBL3988	Homo sapiens	Inhibition	%	8.03
	8180230	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	43.73	CHEMBL3988	Homo sapiens	Inhibition	%	43.73
	8180610	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	5.62	CHEMBL3988	Homo sapiens	Inhibition	%	5.62
	8180758	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-0.17	CHEMBL3988	Homo sapiens	Inhibition	%	-0.17
	8181115	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	89.31	CHEMBL3988	Homo sapiens	Inhibition	%	89.31
	8181246	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.69	CHEMBL3988	Homo sapiens	Inhibition	%	0.69
	8181470	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-4.44	CHEMBL3988	Homo sapiens	Inhibition	%	-4.44
	8181610	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	87.62	CHEMBL3988	Homo sapiens	Inhibition	%	87.62
	8181973	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	22.63	CHEMBL3988	Homo sapiens	Inhibition	%	22.63
	8182136	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	9.7	CHEMBL3988	Homo sapiens	Inhibition	%	9.7
	8182500	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	5.7	CHEMBL3988	Homo sapiens	Inhibition	%	5.7
	8182816	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	8.32	CHEMBL3988	Homo sapiens	Inhibition	%	8.32
	8182938	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	7.96	CHEMBL3988	Homo sapiens	Inhibition	%	7.96
	8183311	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	6.27	CHEMBL3988	Homo sapiens	Inhibition	%	6.27
	8183440	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	6.16	CHEMBL3988	Homo sapiens	Inhibition	%	6.16
	8183664	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.05	CHEMBL3988	Homo sapiens	Inhibition	%	1.05
	8183806	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	14.99	CHEMBL3988	Homo sapiens	Inhibition	%	14.99
	8184166	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.71	CHEMBL3988	Homo sapiens	Inhibition	%	5.71
	8184432	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.45	CHEMBL3988	Homo sapiens	Inhibition	%	8.45
	8184579	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	5.45	CHEMBL3988	Homo sapiens	Inhibition	%	5.45
	8184803	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	6.22	CHEMBL3988	Homo sapiens	Inhibition	%	6.22
	8184960	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	17.14	CHEMBL3988	Homo sapiens	Inhibition	%	17.14
	8185109	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.13	CHEMBL3988	Homo sapiens	Inhibition	%	1.13
	8185333	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.22	CHEMBL3988	Homo sapiens	Inhibition	%	-2.22
	8185464	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	93.48	CHEMBL3988	Homo sapiens	Inhibition	%	93.48
	8185819	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.02	CHEMBL3988	Homo sapiens	Inhibition	%	-2.02
	8185958	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.13	CHEMBL3988	Homo sapiens	Inhibition	%	6.13
	8186182	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	18.89	CHEMBL3988	Homo sapiens	Inhibition	%	18.89
	8186323	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.99	CHEMBL3988	Homo sapiens	Inhibition	%	8.99
	8186487	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	14.56	CHEMBL3988	Homo sapiens	Inhibition	%	14.56
	8186711	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	10.64	CHEMBL3988	Homo sapiens	Inhibition	%	10.64
	8186850	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.99	CHEMBL3988	Homo sapiens	Inhibition	%	1.99
	8187172	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	18.6	CHEMBL3988	Homo sapiens	Inhibition	%	18.6
	8187296	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	15.68	CHEMBL3988	Homo sapiens	Inhibition	%	15.68
	8187520	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.32	CHEMBL3988	Homo sapiens	Inhibition	%	11.32
	8187668	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	12.0	CHEMBL3988	Homo sapiens	Inhibition	%	12.0
	8188021	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	21.18	CHEMBL3988	Homo sapiens	Inhibition	%	21.18
	8188164	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	7.66	CHEMBL3988	Homo sapiens	Inhibition	%	7.66
	8188388	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	12.17	CHEMBL3988	Homo sapiens	Inhibition	%	12.17
	8188523	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	7.26	CHEMBL3988	Homo sapiens	Inhibition	%	7.26
	8188797	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.42	CHEMBL3988	Homo sapiens	Inhibition	%	10.42
	8189169	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.43	CHEMBL3988	Homo sapiens	Inhibition	%	7.43
	8189325	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	55.46	CHEMBL3988	Homo sapiens	Inhibition	%	55.46
	8189698	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1	Outside typical range	CHEMBL207247	=	Inhibition	%	-14.15	CHEMBL3988	Homo sapiens	Inhibition	%	-14.15
	8189830	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	12.26	CHEMBL3988	Homo sapiens	Inhibition	%	12.26
	8190186	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	9.58	CHEMBL3988	Homo sapiens	Inhibition	%	9.58
	8190550	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	19.83	CHEMBL3988	Homo sapiens	Inhibition	%	19.83
	8190687	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	16.42	CHEMBL3988	Homo sapiens	Inhibition	%	16.42
	8191075	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	12.41	CHEMBL3988	Homo sapiens	Inhibition	%	12.41
	8191213	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.86	CHEMBL3988	Homo sapiens	Inhibition	%	6.86
	8191533	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	69.17	CHEMBL3988	Homo sapiens	Inhibition	%	69.17
	8191879	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	24.05	CHEMBL3988	Homo sapiens	Inhibition	%	24.05
	8192028	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.38	CHEMBL3988	Homo sapiens	Inhibition	%	5.38
	8192252	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.6	CHEMBL3988	Homo sapiens	Inhibition	%	5.6
	8192381	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.67	CHEMBL3988	Homo sapiens	Inhibition	%	5.67
	8192749	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	11.65	CHEMBL3988	Homo sapiens	Inhibition	%	11.65
	8192885	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	11.74	CHEMBL3988	Homo sapiens	Inhibition	%	11.74
	8193157	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.93	CHEMBL3988	Homo sapiens	Inhibition	%	11.93
	8193526	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	32.93	CHEMBL3988	Homo sapiens	Inhibition	%	32.93
	8193683	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.61	CHEMBL3988	Homo sapiens	Inhibition	%	7.61
	8193907	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.9	CHEMBL3988	Homo sapiens	Inhibition	%	3.9
	8194056	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-6.53	CHEMBL3988	Homo sapiens	Inhibition	%	-6.53
	8194187	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	15.32	CHEMBL3988	Homo sapiens	Inhibition	%	15.32
	8194411	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	15.93	CHEMBL3988	Homo sapiens	Inhibition	%	15.93
	8194542	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.4	CHEMBL3988	Homo sapiens	Inhibition	%	6.4
	8194909	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	62.84	CHEMBL3988	Homo sapiens	Inhibition	%	62.84
	8195042	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.76	CHEMBL3988	Homo sapiens	Inhibition	%	7.76
	8195266	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	14.67	CHEMBL3988	Homo sapiens	Inhibition	%	14.67
	8195430	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.25	CHEMBL3988	Homo sapiens	Inhibition	%	8.25
	8195569	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.65	CHEMBL3988	Homo sapiens	Inhibition	%	6.65
	8195793	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	9.84	CHEMBL3988	Homo sapiens	Inhibition	%	9.84
	8195891	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	5.75	CHEMBL3988	Homo sapiens	Inhibition	%	5.75
	8196232	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	9.01	CHEMBL3988	Homo sapiens	Inhibition	%	9.01
	8196606	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	11.53	CHEMBL3988	Homo sapiens	Inhibition	%	11.53
	8196734	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	15.68	CHEMBL3988	Homo sapiens	Inhibition	%	15.68
	8197099	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	26.08	CHEMBL3988	Homo sapiens	Inhibition	%	26.08
	8197236	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.94	CHEMBL3988	Homo sapiens	Inhibition	%	2.94
	8197460	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	6.63	CHEMBL3988	Homo sapiens	Inhibition	%	6.63
	8197511	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	10.09	CHEMBL3988	Homo sapiens	Inhibition	%	10.09
	8197735	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	12.71	CHEMBL3988	Homo sapiens	Inhibition	%	12.71
	8197875	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.5	CHEMBL3988	Homo sapiens	Inhibition	%	0.5
	8198256	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.24	CHEMBL3988	Homo sapiens	Inhibition	%	6.24
	8198394	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-8.11	CHEMBL3988	Homo sapiens	Inhibition	%	-8.11
	8198748	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	49.93	CHEMBL3988	Homo sapiens	Inhibition	%	49.93
	8198879	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.28	CHEMBL3988	Homo sapiens	Inhibition	%	8.28
	8199103	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.43	CHEMBL3988	Homo sapiens	Inhibition	%	3.43
	8199251	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.56	CHEMBL3988	Homo sapiens	Inhibition	%	11.56
	8199609	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.27	CHEMBL3988	Homo sapiens	Inhibition	%	9.27
	8199772	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	14.32	CHEMBL3988	Homo sapiens	Inhibition	%	14.32
	8200134	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	7.48	CHEMBL3988	Homo sapiens	Inhibition	%	7.48
	8200238	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.21	CHEMBL3988	Homo sapiens	Inhibition	%	6.21
	8200462	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.45	CHEMBL3988	Homo sapiens	Inhibition	%	3.45
	8200577	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	11.69	CHEMBL3988	Homo sapiens	Inhibition	%	11.69
	8200951	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	52.09	CHEMBL3988	Homo sapiens	Inhibition	%	52.09
	8201081	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	8.34	CHEMBL3988	Homo sapiens	Inhibition	%	8.34
	8201305	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	19.32	CHEMBL3988	Homo sapiens	Inhibition	%	19.32
	8201440	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	9.03	CHEMBL3988	Homo sapiens	Inhibition	%	9.03
	8201797	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.17	CHEMBL3988	Homo sapiens	Inhibition	%	-0.17
	8202076	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	8.08	CHEMBL3988	Homo sapiens	Inhibition	%	8.08
	8202216	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.32	CHEMBL3988	Homo sapiens	Inhibition	%	7.32
	8202607	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.74	CHEMBL3988	Homo sapiens	Inhibition	%	3.74
	8202732	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	11.95	CHEMBL3988	Homo sapiens	Inhibition	%	11.95
	8202956	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	14.77	CHEMBL3988	Homo sapiens	Inhibition	%	14.77
	8203086	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	11.13	CHEMBL3988	Homo sapiens	Inhibition	%	11.13
	8203441	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	8.51	CHEMBL3988	Homo sapiens	Inhibition	%	8.51
	8203587	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	15.18	CHEMBL3988	Homo sapiens	Inhibition	%	15.18
	8203945	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	13.07	CHEMBL3988	Homo sapiens	Inhibition	%	13.07
	8204111	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	31.13	CHEMBL3988	Homo sapiens	Inhibition	%	31.13
	8204335	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	80.59	CHEMBL3988	Homo sapiens	Inhibition	%	80.59
	8204472	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	91.24	CHEMBL3988	Homo sapiens	Inhibition	%	91.24
	8204801	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	23.33	CHEMBL3988	Homo sapiens	Inhibition	%	23.33
	8204916	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	14.88	CHEMBL3988	Homo sapiens	Inhibition	%	14.88
	8205140	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	55.34	CHEMBL3988	Homo sapiens	Inhibition	%	55.34
	8205289	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.24	CHEMBL3988	Homo sapiens	Inhibition	%	10.24
	8205649	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.65	CHEMBL3988	Homo sapiens	Inhibition	%	11.65
	8205788	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	10.44	CHEMBL3988	Homo sapiens	Inhibition	%	10.44
	8206144	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	18.61	CHEMBL3988	Homo sapiens	Inhibition	%	18.61
	8206420	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.97	CHEMBL3988	Homo sapiens	Inhibition	%	6.97
	8206563	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-6.57	CHEMBL3988	Homo sapiens	Inhibition	%	-6.57
	8206787	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.56	CHEMBL3988	Homo sapiens	Inhibition	%	-2.56
	8206967	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.85	CHEMBL3988	Homo sapiens	Inhibition	%	4.85
	8207317	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	11.0	CHEMBL3988	Homo sapiens	Inhibition	%	11.0
	8207447	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	14.77	CHEMBL3988	Homo sapiens	Inhibition	%	14.77
	8207803	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	14.22	CHEMBL3988	Homo sapiens	Inhibition	%	14.22
	8207948	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	10.03	CHEMBL3988	Homo sapiens	Inhibition	%	10.03
	8208172	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.87	CHEMBL3988	Homo sapiens	Inhibition	%	5.87
	8208304	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.66	CHEMBL3988	Homo sapiens	Inhibition	%	8.66
	8208694	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	6.86	CHEMBL3988	Homo sapiens	Inhibition	%	6.86
	8208827	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	90.94	CHEMBL3988	Homo sapiens	Inhibition	%	90.94
	8209156	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.37	CHEMBL3988	Homo sapiens	Inhibition	%	2.37
	8209496	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.9	CHEMBL3988	Homo sapiens	Inhibition	%	7.9
	8209646	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.94	CHEMBL3988	Homo sapiens	Inhibition	%	10.94
	8210006	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-8.98	CHEMBL3988	Homo sapiens	Inhibition	%	-8.98
	8210147	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.26	CHEMBL3988	Homo sapiens	Inhibition	%	8.26
	8210371	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	12.91	CHEMBL3988	Homo sapiens	Inhibition	%	12.91
	8210507	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-7.32	CHEMBL3988	Homo sapiens	Inhibition	%	-7.32
	8210766	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.29	CHEMBL3988	Homo sapiens	Inhibition	%	6.29
	8211134	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.09	CHEMBL3988	Homo sapiens	Inhibition	%	9.09
	8211304	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.54	CHEMBL3988	Homo sapiens	Inhibition	%	3.54
	8211651	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	14.77	CHEMBL3988	Homo sapiens	Inhibition	%	14.77
	8211780	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	15.22	CHEMBL3988	Homo sapiens	Inhibition	%	15.22
	8212004	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	39.2	CHEMBL3988	Homo sapiens	Inhibition	%	39.2
	8212136	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.09	CHEMBL3988	Homo sapiens	Inhibition	%	8.09
	8212501	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.63	CHEMBL3988	Homo sapiens	Inhibition	%	7.63
	8212634	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	14.05	CHEMBL3988	Homo sapiens	Inhibition	%	14.05
	8212858	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	11.33	CHEMBL3988	Homo sapiens	Inhibition	%	11.33
	8213028	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	10.24	CHEMBL3988	Homo sapiens	Inhibition	%	10.24
	8213157	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.99	CHEMBL3988	Homo sapiens	Inhibition	%	6.99
	8213381	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.96	CHEMBL3988	Homo sapiens	Inhibition	%	5.96
	8213485	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.94	CHEMBL3988	Homo sapiens	Inhibition	%	2.94
	8213822	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	8.8	CHEMBL3988	Homo sapiens	Inhibition	%	8.8
	8213969	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.83	CHEMBL3988	Homo sapiens	Inhibition	%	4.83
	8214193	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.43	CHEMBL3988	Homo sapiens	Inhibition	%	1.43
	8214330	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	18.88	CHEMBL3988	Homo sapiens	Inhibition	%	18.88
	8214688	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	17.14	CHEMBL3988	Homo sapiens	Inhibition	%	17.14
	8214840	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.58	CHEMBL3988	Homo sapiens	Inhibition	%	-3.58
	8215091	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.1	CHEMBL3988	Homo sapiens	Inhibition	%	5.1
	8215315	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.96	CHEMBL3988	Homo sapiens	Inhibition	%	7.96
	8215468	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.17	CHEMBL3988	Homo sapiens	Inhibition	%	4.17
	8215632	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.87	CHEMBL3988	Homo sapiens	Inhibition	%	6.87
	8215856	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.19	CHEMBL3988	Homo sapiens	Inhibition	%	3.19
	8215975	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.3	CHEMBL3988	Homo sapiens	Inhibition	%	9.3
	8216318	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	10.12	CHEMBL3988	Homo sapiens	Inhibition	%	10.12
	8216454	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.03	CHEMBL3988	Homo sapiens	Inhibition	%	5.03
	8216816	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.17	CHEMBL3988	Homo sapiens	Inhibition	%	4.17
	8217174	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	10.77	CHEMBL3988	Homo sapiens	Inhibition	%	10.77
	8217348	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.49	CHEMBL3988	Homo sapiens	Inhibition	%	4.49
	8217703	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	15.18	CHEMBL3988	Homo sapiens	Inhibition	%	15.18
	8217804	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-6.1	CHEMBL3988	Homo sapiens	Inhibition	%	-6.1
	8218028	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-6.97	CHEMBL3988	Homo sapiens	Inhibition	%	-6.97
	8218143	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.96	CHEMBL3988	Homo sapiens	Inhibition	%	6.96
	8218494	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.76	CHEMBL3988	Homo sapiens	Inhibition	%	2.76
	8218637	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	26.82	CHEMBL3988	Homo sapiens	Inhibition	%	26.82
	8218992	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	62.86	CHEMBL3988	Homo sapiens	Inhibition	%	62.86
	8219152	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.11	CHEMBL3988	Homo sapiens	Inhibition	%	-5.11
	8219376	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-9.05	CHEMBL3988	Homo sapiens	Inhibition	%	-9.05
	8219626	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	9.12	CHEMBL3988	Homo sapiens	Inhibition	%	9.12
	8219787	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.51	CHEMBL3988	Homo sapiens	Inhibition	%	7.51
	8220180	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	10.1	CHEMBL3988	Homo sapiens	Inhibition	%	10.1
	8220309	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	12.47	CHEMBL3988	Homo sapiens	Inhibition	%	12.47
	8220647	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	8.59	CHEMBL3988	Homo sapiens	Inhibition	%	8.59
	8220785	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.97	CHEMBL3988	Homo sapiens	Inhibition	%	7.97
	8221009	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.3	CHEMBL3988	Homo sapiens	Inhibition	%	3.3
	8221145	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.79	CHEMBL3988	Homo sapiens	Inhibition	%	5.79
	8221502	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.47	CHEMBL3988	Homo sapiens	Inhibition	%	8.47
	8221667	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.79	CHEMBL3988	Homo sapiens	Inhibition	%	4.79
	8222022	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	57.27	CHEMBL3988	Homo sapiens	Inhibition	%	57.27
	8222344	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	9.55	CHEMBL3988	Homo sapiens	Inhibition	%	9.55
	8222478	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	9.28	CHEMBL3988	Homo sapiens	Inhibition	%	9.28
	8222820	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	15.95	CHEMBL3988	Homo sapiens	Inhibition	%	15.95
	8222964	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.28	CHEMBL3988	Homo sapiens	Inhibition	%	87.28
	8223188	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	87.64	CHEMBL3988	Homo sapiens	Inhibition	%	87.64
	8223317	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	13.45	CHEMBL3988	Homo sapiens	Inhibition	%	13.45
	8223702	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.25	CHEMBL3988	Homo sapiens	Inhibition	%	1.25
	8223952	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	9.07	CHEMBL3988	Homo sapiens	Inhibition	%	9.07
	8224114	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.15	CHEMBL3988	Homo sapiens	Inhibition	%	3.15
	8224338	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	7.04	CHEMBL3988	Homo sapiens	Inhibition	%	7.04
	8224508	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.53	CHEMBL3988	Homo sapiens	Inhibition	%	6.53
	8224643	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	7.7	CHEMBL3988	Homo sapiens	Inhibition	%	7.7
	8224867	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	13.1	CHEMBL3988	Homo sapiens	Inhibition	%	13.1
	8224981	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	8.02	CHEMBL3988	Homo sapiens	Inhibition	%	8.02
	8225339	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	10.09	CHEMBL3988	Homo sapiens	Inhibition	%	10.09
	8225477	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.69	CHEMBL3988	Homo sapiens	Inhibition	%	2.69
	8225701	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.05	CHEMBL3988	Homo sapiens	Inhibition	%	4.05
	8225836	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	11.15	CHEMBL3988	Homo sapiens	Inhibition	%	11.15
	8225994	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.75	CHEMBL3988	Homo sapiens	Inhibition	%	0.75
	8226218	CHEMBL1962273	GSK_PKIS: EPHA4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.23	CHEMBL3988	Homo sapiens	Inhibition	%	4.23
	8226343	CHEMBL1962272	GSK_PKIS: EPHA4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	6.14	CHEMBL3988	Homo sapiens	Inhibition	%	6.14
	10838570	CHEMBL2014143	Inhibition of EPHA4 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL3988	Homo sapiens	INH	%	0.0
	10839603	CHEMBL2015009	Inhibition of EPH-A4 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	13.0	CHEMBL3988	Homo sapiens	Activity	%	13.0
	10839675	CHEMBL2015952	Inhibition of EPH-A4 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	52.0	CHEMBL3988	Homo sapiens	Activity	%	52.0
	12046289	CHEMBL2156526	Inhibition of EphA4 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-2.5	CHEMBL3988	Homo sapiens	INH	%	-2.5
	12170817	CHEMBL2210341	Inhibition of EPH-A4 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	12172118	CHEMBL2213945	Inhibition of EPH-A4 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL3988	Homo sapiens	Activity	%	86.0
	12173637	CHEMBL2214013	Inhibition of EPHA4 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	12208380	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	86.0	CHEMBL3988	Homo sapiens	Residual Activity	%	86.0
	12208381	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL3988	Homo sapiens	Residual Activity	%	87.0
	12208382	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	98.0	CHEMBL3988	Homo sapiens	Residual Activity	%	98.0
	12208383	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208384	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208385	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208386	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12208387	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	73.0	CHEMBL3988	Homo sapiens	Residual Activity	%	73.0
	12208388	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	79.0	CHEMBL3988	Homo sapiens	Residual Activity	%	79.0
	12208389	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	68.0	CHEMBL3988	Homo sapiens	Residual Activity	%	68.0
	12208390	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	79.0	CHEMBL3988	Homo sapiens	Residual Activity	%	79.0
	12208391	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208392	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12208393	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208394	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12208395	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12208396	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12208397	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	90.0	CHEMBL3988	Homo sapiens	Residual Activity	%	90.0
	12208398	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	90.0	CHEMBL3988	Homo sapiens	Residual Activity	%	90.0
	12208399	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12208400	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12208401	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208402	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12208403	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12208404	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208405	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12208406	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208407	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12208408	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	92.0	CHEMBL3988	Homo sapiens	Residual Activity	%	92.0
	12208409	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	82.0	CHEMBL3988	Homo sapiens	Residual Activity	%	82.0
	12208410	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	93.0	CHEMBL3988	Homo sapiens	Residual Activity	%	93.0
	12208411	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208412	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	55.0	CHEMBL3988	Homo sapiens	Residual Activity	%	55.0
	12208413	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208414	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	62.0	CHEMBL3988	Homo sapiens	Residual Activity	%	62.0
	12208415	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208416	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3988	Homo sapiens	Residual Activity	%	0.0
	12208417	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208418	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12208419	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	92.0	CHEMBL3988	Homo sapiens	Residual Activity	%	92.0
	12208420	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12208421	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	92.0	CHEMBL3988	Homo sapiens	Residual Activity	%	92.0
	12208422	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12208423	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	91.0	CHEMBL3988	Homo sapiens	Residual Activity	%	91.0
	12208424	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	80.0	CHEMBL3988	Homo sapiens	Residual Activity	%	80.0
	12208425	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208426	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	83.0	CHEMBL3988	Homo sapiens	Residual Activity	%	83.0
	12208427	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208428	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12208429	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	73.0	CHEMBL3988	Homo sapiens	Residual Activity	%	73.0
	12208430	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	86.0	CHEMBL3988	Homo sapiens	Residual Activity	%	86.0
	12208431	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12208432	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12208433	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12208434	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12208435	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12208436	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208437	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	94.0	CHEMBL3988	Homo sapiens	Residual Activity	%	94.0
	12208438	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	43.0	CHEMBL3988	Homo sapiens	Residual Activity	%	43.0
	12208439	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12208440	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12208441	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208442	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208443	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12208444	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208445	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208446	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12208447	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12208448	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208449	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	93.0	CHEMBL3988	Homo sapiens	Residual Activity	%	93.0
	12208450	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208451	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208452	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12208453	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	43.0	CHEMBL3988	Homo sapiens	Residual Activity	%	43.0
	12208454	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12208455	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	71.0	CHEMBL3988	Homo sapiens	Residual Activity	%	71.0
	12208456	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208457	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12208458	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	49.0	CHEMBL3988	Homo sapiens	Residual Activity	%	49.0
	12208459	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	75.0	CHEMBL3988	Homo sapiens	Residual Activity	%	75.0
	12208460	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208461	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	77.0	CHEMBL3988	Homo sapiens	Residual Activity	%	77.0
	12208462	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208463	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	47.0	CHEMBL3988	Homo sapiens	Residual Activity	%	47.0
	12208464	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208465	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208466	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	86.0	CHEMBL3988	Homo sapiens	Residual Activity	%	86.0
	12208467	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12208468	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12208469	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12208470	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208471	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	4.0	CHEMBL3988	Homo sapiens	Residual Activity	%	4.0
	12208472	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	63.0	CHEMBL3988	Homo sapiens	Residual Activity	%	63.0
	12208473	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12208474	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	73.0	CHEMBL3988	Homo sapiens	Residual Activity	%	73.0
	12208475	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	98.0	CHEMBL3988	Homo sapiens	Residual Activity	%	98.0
	12208476	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	116.0	CHEMBL3988	Homo sapiens	Residual Activity	%	116.0
	12208477	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12208478	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12208479	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208480	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	39.0	CHEMBL3988	Homo sapiens	Residual Activity	%	39.0
	12208481	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12208482	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12208483	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	84.0	CHEMBL3988	Homo sapiens	Residual Activity	%	84.0
	12208484	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12208485	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	77.0	CHEMBL3988	Homo sapiens	Residual Activity	%	77.0
	12208486	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12208487	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12208488	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	114.0	CHEMBL3988	Homo sapiens	Residual Activity	%	114.0
	12208489	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208490	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12208491	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12208492	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12208493	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	87.0	CHEMBL3988	Homo sapiens	Residual Activity	%	87.0
	12208494	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	76.0	CHEMBL3988	Homo sapiens	Residual Activity	%	76.0
	12250488	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250489	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250490	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250491	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250492	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250493	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250494	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250495	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250496	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250497	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250498	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	118.0	CHEMBL3988	Homo sapiens	Residual Activity	%	118.0
	12250499	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250500	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250501	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	47.0	CHEMBL3988	Homo sapiens	Residual Activity	%	47.0
	12250502	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250503	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250504	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250505	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250506	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250507	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250508	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250509	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250510	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250511	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250512	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250513	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	86.0	CHEMBL3988	Homo sapiens	Residual Activity	%	86.0
	12250514	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250515	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	89.0	CHEMBL3988	Homo sapiens	Residual Activity	%	89.0
	12250516	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL3988	Homo sapiens	Residual Activity	%	99.0
	12250517	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250518	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250519	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	26.0	CHEMBL3988	Homo sapiens	Residual Activity	%	26.0
	12250520	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250521	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	114.0	CHEMBL3988	Homo sapiens	Residual Activity	%	114.0
	12250522	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250523	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250524	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12250525	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250526	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	114.0	CHEMBL3988	Homo sapiens	Residual Activity	%	114.0
	12250527	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250528	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	116.0	CHEMBL3988	Homo sapiens	Residual Activity	%	116.0
	12250529	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	119.0	CHEMBL3988	Homo sapiens	Residual Activity	%	119.0
	12250530	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250531	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250532	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250533	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250534	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	114.0	CHEMBL3988	Homo sapiens	Residual Activity	%	114.0
	12250535	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12250536	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250537	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	119.0	CHEMBL3988	Homo sapiens	Residual Activity	%	119.0
	12250538	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250539	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250540	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250541	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250542	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	117.0	CHEMBL3988	Homo sapiens	Residual Activity	%	117.0
	12250543	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250544	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250545	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250546	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250547	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12250548	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	99.0	CHEMBL3988	Homo sapiens	Residual Activity	%	99.0
	12250549	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250550	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	111.0	CHEMBL3988	Homo sapiens	Residual Activity	%	111.0
	12250551	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250552	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL3988	Homo sapiens	Residual Activity	%	116.0
	12250553	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250554	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250555	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250556	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250557	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12250558	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250559	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250560	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250561	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	118.0	CHEMBL3988	Homo sapiens	Residual Activity	%	118.0
	12250562	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	117.0	CHEMBL3988	Homo sapiens	Residual Activity	%	117.0
	12250563	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12250564	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	116.0	CHEMBL3988	Homo sapiens	Residual Activity	%	116.0
	12250565	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250566	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250567	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	15.0	CHEMBL3988	Homo sapiens	Residual Activity	%	15.0
	12250568	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250569	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250570	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250571	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250572	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250573	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250574	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250575	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250576	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250577	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250578	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250579	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250580	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250581	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250582	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250583	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250584	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250585	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250586	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250587	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250588	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	98.0	CHEMBL3988	Homo sapiens	Residual Activity	%	98.0
	12250589	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	83.0	CHEMBL3988	Homo sapiens	Residual Activity	%	83.0
	12250590	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250591	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250592	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250593	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250594	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250595	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250596	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250597	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250598	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250599	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250600	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12250601	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	117.0	CHEMBL3988	Homo sapiens	Residual Activity	%	117.0
	12250602	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250603	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250604	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	93.0	CHEMBL3988	Homo sapiens	Residual Activity	%	93.0
	12250605	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250606	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250607	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	118.0	CHEMBL3988	Homo sapiens	Residual Activity	%	118.0
	12250608	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250609	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	98.0	CHEMBL3988	Homo sapiens	Residual Activity	%	98.0
	12250610	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250611	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250612	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	92.0	CHEMBL3988	Homo sapiens	Residual Activity	%	92.0
	12250613	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250614	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250615	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250616	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	108.0	CHEMBL3988	Homo sapiens	Residual Activity	%	108.0
	12250617	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12250618	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	110.0	CHEMBL3988	Homo sapiens	Residual Activity	%	110.0
	12250619	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250620	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	105.0	CHEMBL3988	Homo sapiens	Residual Activity	%	105.0
	12250621	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250622	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	48.0	CHEMBL3988	Homo sapiens	Residual Activity	%	48.0
	12250623	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	107.0	CHEMBL3988	Homo sapiens	Residual Activity	%	107.0
	12250624	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	120.0	CHEMBL3988	Homo sapiens	Residual Activity	%	120.0
	12250625	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	113.0	CHEMBL3988	Homo sapiens	Residual Activity	%	113.0
	12250626	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	109.0	CHEMBL3988	Homo sapiens	Residual Activity	%	109.0
	12250627	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	120.0	CHEMBL3988	Homo sapiens	Residual Activity	%	120.0
	12250628	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	116.0	CHEMBL3988	Homo sapiens	Residual Activity	%	116.0
	12250629	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	111.0	CHEMBL3988	Homo sapiens	Residual Activity	%	111.0
	12250630	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	106.0	CHEMBL3988	Homo sapiens	Residual Activity	%	106.0
	12250631	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250632	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	118.0	CHEMBL3988	Homo sapiens	Residual Activity	%	118.0
	12250633	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	121.0	CHEMBL3988	Homo sapiens	Residual Activity	%	121.0
	12250634	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	112.0	CHEMBL3988	Homo sapiens	Residual Activity	%	112.0
	12250635	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	123.0	CHEMBL3988	Homo sapiens	Residual Activity	%	123.0
	12250636	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	111.0	CHEMBL3988	Homo sapiens	Residual Activity	%	111.0
	12250637	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	114.0	CHEMBL3988	Homo sapiens	Residual Activity	%	114.0
	12250638	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	115.0	CHEMBL3988	Homo sapiens	Residual Activity	%	115.0
	12250639	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	120.0	CHEMBL3988	Homo sapiens	Residual Activity	%	120.0
	12250640	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	120.0	CHEMBL3988	Homo sapiens	Residual Activity	%	120.0
	12250641	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	126.0	CHEMBL3988	Homo sapiens	Residual Activity	%	126.0
	12250642	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	125.0	CHEMBL3988	Homo sapiens	Residual Activity	%	125.0
	12250643	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	125.0	CHEMBL3988	Homo sapiens	Residual Activity	%	125.0
	12250644	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	117.0	CHEMBL3988	Homo sapiens	Residual Activity	%	117.0
	12250645	CHEMBL2219042	Millipore: Percentage of residual kinase activity of EPHA4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250646	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250647	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	86.0	CHEMBL3988	Homo sapiens	Residual Activity	%	86.0
	12250648	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250649	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12250650	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250651	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL3988	Homo sapiens	Residual Activity	%	97.0
	12250652	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL3988	Homo sapiens	Residual Activity	%	89.0
	12250653	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	57.0	CHEMBL3988	Homo sapiens	Residual Activity	%	57.0
	12250654	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250655	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	88.0	CHEMBL3988	Homo sapiens	Residual Activity	%	88.0
	12250656	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	91.0	CHEMBL3988	Homo sapiens	Residual Activity	%	91.0
	12250657	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250658	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL3988	Homo sapiens	Residual Activity	%	92.0
	12250659	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	5.0	CHEMBL3988	Homo sapiens	Residual Activity	%	5.0
	12250660	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	91.0	CHEMBL3988	Homo sapiens	Residual Activity	%	91.0
	12250661	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	96.0	CHEMBL3988	Homo sapiens	Residual Activity	%	96.0
	12250662	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	85.0	CHEMBL3988	Homo sapiens	Residual Activity	%	85.0
	12250663	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	102.0	CHEMBL3988	Homo sapiens	Residual Activity	%	102.0
	12250664	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250665	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	90.0	CHEMBL3988	Homo sapiens	Residual Activity	%	90.0
	12250666	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	91.0	CHEMBL3988	Homo sapiens	Residual Activity	%	91.0
	12250667	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	83.0	CHEMBL3988	Homo sapiens	Residual Activity	%	83.0
	12250668	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250669	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	99.0	CHEMBL3988	Homo sapiens	Residual Activity	%	99.0
	12250670	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250671	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	31.0	CHEMBL3988	Homo sapiens	Residual Activity	%	31.0
	12250672	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	81.0	CHEMBL3988	Homo sapiens	Residual Activity	%	81.0
	12250673	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	41.0	CHEMBL3988	Homo sapiens	Residual Activity	%	41.0
	12250674	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250675	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	95.0	CHEMBL3988	Homo sapiens	Residual Activity	%	95.0
	12250676	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250677	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	3.0	CHEMBL3988	Homo sapiens	Residual Activity	%	3.0
	12250678	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	81.0	CHEMBL3988	Homo sapiens	Residual Activity	%	81.0
	12250679	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250680	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250681	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	101.0	CHEMBL3988	Homo sapiens	Residual Activity	%	101.0
	12250682	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	80.0	CHEMBL3988	Homo sapiens	Residual Activity	%	80.0
	12250683	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250684	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250685	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	103.0	CHEMBL3988	Homo sapiens	Residual Activity	%	103.0
	12250686	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	100.0	CHEMBL3988	Homo sapiens	Residual Activity	%	100.0
	12250687	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL3988	Homo sapiens	Residual Activity	%	104.0
	12250688	CHEMBL2219043	Millipore: Percentage of residual kinase activity of EPHA4 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	91.0	CHEMBL3988	Homo sapiens	Residual Activity	%	91.0
	12649142	CHEMBL2329874	Displacement of ephrin-A1-Fc from EphA4 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	2700.0	CHEMBL3988	Homo sapiens	IC50	uM	2.7
	12673057	CHEMBL2345614	Inhibition of recombinant EPH-A4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	41.0	CHEMBL3988	Homo sapiens	Activity	%	41.0
	12673058	CHEMBL2345614	Inhibition of recombinant EPH-A4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	22.0	CHEMBL3988	Homo sapiens	Activity	%	22.0
	12674221	CHEMBL2344195	Inhibition of human Eph-A4 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	5.0	CHEMBL3988	Homo sapiens	Activity	%	5.0
Active	12688501	CHEMBL2339602	Agonist activity at IgG1 Fc region fused-immobilized EphA4 (unknown origin) assessed as inhibition of EphA4/ephrin-A5 AP interaction at 10 uM incubated for 3 hrs by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCNC(=O)CCCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(C)C)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)O		CHEMBL2337010		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
	12728846	CHEMBL2352919	Inhibition of EPHA4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	79.0	CHEMBL3988	Homo sapiens	Activity	%	79.0
	12729986	CHEMBL2353630	Inhibition of EPHA4 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL3988	Homo sapiens	Activity	%	96.0
	12730234	CHEMBL2352919	Inhibition of EPHA4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL3988	Homo sapiens	Activity	%	94.0
	12730864	CHEMBL2352211	Inhibition of EPHA4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL3988	Homo sapiens	Activity	%	95.0
	13375878	CHEMBL2405142	Inhibition of EPHA4 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL3988	Homo sapiens	INH	%	-1.0
	13442371	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13445506	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13448561	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13448697	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13451492	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13454677	CHEMBL2427802	Competitive binding affinity to EPHA4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	13872159	CHEMBL3101785	Inhibition of human EphA4 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	78.0	CHEMBL3988	Homo sapiens	Activity	%	78.0
	14582486	CHEMBL3242338	Inhibition of human EphA4 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	119.0	CHEMBL3988	Homo sapiens	Activity	%	119.0
	14664158	CHEMBL3270868	Inhibition of EPHA4 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	58.0	CHEMBL3988	Homo sapiens	INH	%	58.0
	14664159	CHEMBL3270868	Inhibition of EPHA4 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	72.0	CHEMBL3988	Homo sapiens	INH	%	72.0
	14664160	CHEMBL3270868	Inhibition of EPHA4 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	100.0	CHEMBL3988	Homo sapiens	INH	%	100.0
	15018581	CHEMBL3361895	Inhibition of EPHA4 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	6.5	CHEMBL3988	Homo sapiens	INH	%	6.5
	15072601	CHEMBL3382661	Inhibition of EPHA4 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	125.0	CHEMBL3988	Homo sapiens	Activity	%	125.0
	15091098	CHEMBL3381531	Inhibition of human recombinant EphA3 kinase using Ulight-TK peptide substrate assessed as remaining enzyme activity at 1 uM after 60 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	101.0	CHEMBL3988	Homo sapiens	Activity	%	101.0
	15251804	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	80.0	CHEMBL3988	Homo sapiens	Activity	%	80.0
	15251993	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	77.0	CHEMBL3988	Homo sapiens	Activity	%	77.0
	15252638	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	101.0	CHEMBL3988	Homo sapiens	Activity	%	101.0
	15252740	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	121.0	CHEMBL3988	Homo sapiens	Activity	%	121.0
	15252842	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	90.0	CHEMBL3988	Homo sapiens	Activity	%	90.0
	15253516	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	99.0	CHEMBL3988	Homo sapiens	Activity	%	99.0
	15253618	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	219.0	CHEMBL3988	Homo sapiens	Activity	%	219.0
	15253720	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	98.0	CHEMBL3988	Homo sapiens	Activity	%	98.0
	15254386	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	15254488	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	87.0	CHEMBL3988	Homo sapiens	Activity	%	87.0
	15254590	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	106.0	CHEMBL3988	Homo sapiens	Activity	%	106.0
	15255280	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	83.0	CHEMBL3988	Homo sapiens	Activity	%	83.0
	15255383	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	87.0	CHEMBL3988	Homo sapiens	Activity	%	87.0
	15255485	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	15256217	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	94.0	CHEMBL3988	Homo sapiens	Activity	%	94.0
	15256319	CHEMBL3428743	Inhibition of EPH-A4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	103.0	CHEMBL3988	Homo sapiens	Activity	%	103.0
	15756025	CHEMBL3630360	Inhibition of EPHA4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	70.49	CHEMBL3988	Homo sapiens	INH	%	70.49
	15757034	CHEMBL3630360	Inhibition of EPHA4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	97.0	CHEMBL3988	Homo sapiens	INH	%	97.0
	15758697	CHEMBL3630360	Inhibition of EPHA4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	14.35	CHEMBL3988	Homo sapiens	INH	%	14.35
Dose-dependent effect	16392489	CHEMBL3738304	Displacement of biotinylated ephrin-A1-Fc from EphA4 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
	16392514	CHEMBL3738304	Displacement of biotinylated ephrin-A1-Fc from EphA4 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-A1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	3800.0	CHEMBL3988	Homo sapiens	IC50	uM	3.8
	16421906	CHEMBL3750388	Inhibition of EPHA4 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16431814	CHEMBL3749437	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16450829	CHEMBL3762685	Inhibition of EPHA4 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	23.1	CHEMBL3988	Homo sapiens	INH	%	23.1
	16495979	CHEMBL3778570	Inhibition of N-terminal His6-tagged recombinant human EPHA4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	2.0	CHEMBL3988	Homo sapiens	Activity	%	2.0
	16508166	CHEMBL3778570	Inhibition of N-terminal His6-tagged recombinant human EPHA4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-6.0	CHEMBL3988	Homo sapiens	Activity	%	-6.0
	16509143	CHEMBL3778570	Inhibition of N-terminal His6-tagged recombinant human EPHA4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-1.0	CHEMBL3988	Homo sapiens	Activity	%	-1.0
	16540765	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16540766	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	4700.0	CHEMBL3988	Homo sapiens	IC50	uM	4.7
	16540767	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	9.0	CHEMBL3988	Homo sapiens	IC50	uM	0.009
	16540768	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16540769	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16540770	CHEMBL3789981	Inhibition of EphA4 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	16578371	CHEMBL3802056	Inhibition of partial length wild type human EPHA4 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	90.0	CHEMBL3988	Homo sapiens	Activity	%	90.0
	16593543	CHEMBL3811546	Inhibition of GST-tagged human recombinant EPHA4 (616 to 887 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL3988	Homo sapiens	INH	%	40.0
	16611857	CHEMBL3816749	Inhibition of human EPHA4 (570 to 986 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	15.0	CHEMBL3988	Homo sapiens	Activity	%	15.0
	16614460	CHEMBL3816590	Inhibition of human EPHA4 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	13.0	CHEMBL3988	Homo sapiens	INH	%	13.0
	16618231	CHEMBL3816224	Inhibition of recombinant human GST-tagged cytoplasmic EPHA4 (616 to 887 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	16654249	CHEMBL3829895	Inhibition of human EPHA4 (580 to 986 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	53.0	CHEMBL3988	Homo sapiens	Activity	%	53.0
Inactive	17899623	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899624	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899625	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899626	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899627	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899628	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899629	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899630	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899631	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899632	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899633	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899634	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899635	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899636	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899637	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899638	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899639	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	8131.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	8131.0
Inactive	17899640	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899641	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899642	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899643	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899644	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899645	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899646	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899647	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899648	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899649	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899650	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899651	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899652	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899653	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899654	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899655	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899656	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899657	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	1033.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	1033.0
Inactive	17899658	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899659	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899660	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899661	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899662	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899663	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899664	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899665	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899666	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	43942.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	43942.0
Inactive	17899667	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899668	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899669	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899670	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899671	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899672	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899673	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	7.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	7.0
Inactive	17899674	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899675	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899676	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899677	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899678	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	7057.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	7057.0
Inactive	17899679	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899680	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899681	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	59.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	59.0
Inactive	17899682	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899683	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899684	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899685	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	22.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	22.0
Inactive	17899686	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899687	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899688	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899689	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899690	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899691	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	917.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	917.0
Inactive	17899692	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899693	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899694	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	17152.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	17152.0
Inactive	17899695	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899696	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899697	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899698	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899699	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899700	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899701	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899702	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899703	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899704	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899705	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899706	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899707	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899708	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	167.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	167.0
Inactive	17899709	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899710	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899711	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	930.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	930.0
Inactive	17899712	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899713	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899714	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899715	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899716	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899717	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899718	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899719	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	440.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	440.0
Inactive	17899720	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899721	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899722	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899723	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899724	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	5563.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	5563.0
Inactive	17899725	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899726	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899727	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899728	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	2.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	2.0
Inactive	17899729	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899730	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899731	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899732	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899733	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899734	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899735	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899736	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	1980.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	1980.0
Inactive	17899737	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899738	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899739	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899740	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899741	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899742	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899743	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899744	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899745	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899746	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	159.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	159.0
Active	17899747	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	455.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	455.0
Inactive	17899748	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899749	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899750	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899751	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899752	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899753	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899754	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899755	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899756	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899757	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899758	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899759	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899760	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899761	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899762	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899763	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899764	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899765	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899766	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899767	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899768	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	181.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	181.0
Inactive	17899769	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899770	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899771	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899772	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899773	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899774	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3275.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	3275.0
Inactive	17899775	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899776	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899777	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17899778	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	1930.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	1930.0
Inactive	17899779	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899780	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899781	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899782	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899783	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899784	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899785	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899786	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899787	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899788	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899789	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899790	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899791	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899792	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899793	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899794	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899795	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899796	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899797	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899798	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899799	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899800	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899801	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899802	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899803	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899804	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899805	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899806	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899807	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899808	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899809	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899810	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899811	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899812	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899813	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899814	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899815	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899816	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899817	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899818	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899819	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899820	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899821	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899822	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899823	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899824	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899825	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899826	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899827	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899828	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899829	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899830	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899831	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899832	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899833	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3461.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	3461.0
Inactive	17899834	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899835	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Active	17899836	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	7399.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	7399.0
Inactive	17899837	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899838	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899839	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899840	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899841	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899842	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899843	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899844	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899845	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899846	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899847	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899848	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899849	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899850	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899851	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899852	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899853	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899854	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899855	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899856	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899857	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899858	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899859	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899860	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899861	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899862	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899863	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899864	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17899865	CHEMBL3991702	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3988	Homo sapiens	Kd apparent	nM	30000.0
	18052959	CHEMBL4011848	Inhibition of EPHA4 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.6	CHEMBL3988	Homo sapiens	INH	%	-2.6
	18114378	CHEMBL4025116	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	83.0	CHEMBL3988	Homo sapiens	Activity	%	83.0
Active	18149664	CHEMBL4033349	Inhibition of human EPHA4 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
Active	18149665	CHEMBL4033349	Inhibition of human EPHA4 at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
	18203640	CHEMBL4043927	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18232092	CHEMBL4050410	Inhibition of human EPH-A4 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	104.0	CHEMBL3988	Homo sapiens	Activity	%	104.0
	18253791	CHEMBL4055180	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18253792	CHEMBL4055180	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18265778	CHEMBL4057228	Inhibition of EPHA4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.7	CHEMBL3988	Homo sapiens	INH	%	0.7
	18265976	CHEMBL4057426	Inhibition of EPHA4 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.3	CHEMBL3988	Homo sapiens	INH	%	2.3
	18282749	CHEMBL4120334	Inhibition of EPHA4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.7	CHEMBL3988	Homo sapiens	INH	%	0.7
	18282976	CHEMBL4120561	Inhibition of EPHA4 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	2.0	CHEMBL3988	Homo sapiens	INH	%	2.0
	18283200	CHEMBL4120785	Inhibition of EPHA4 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-2.3	CHEMBL3988	Homo sapiens	INH	%	-2.3
	18440182	CHEMBL4157006	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18449881	CHEMBL4178115	Inhibition of human EPHA4 (570 to 986 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	104.0	CHEMBL3988	Homo sapiens	Activity	%	104.0
	18465742	CHEMBL4181665	Inhibition of EphA4 (unknown origin)	B	CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL4216073	=	IC50	nM	74.0	CHEMBL3988	Homo sapiens	IC50	uM	0.074
	18484622	CHEMBL4185785	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	97.0	CHEMBL3988	Homo sapiens	Activity	%	97.0
	18484999	CHEMBL4185785	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	18507805	CHEMBL4190957	Inhibition of recombinant human EPHA4 (601 to 892 residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	1.0	CHEMBL3988	Homo sapiens	INH	%	1.0
Active	18571315	CHEMBL4221072	Binding affinity to EphA4-LBD (unknown origin) by ITC assay	B	CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)N[C@@H](CCO)C(=O)N[C@@H](CO)C(N)=O		CHEMBL4225642		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	18571316	CHEMBL4221072	Binding affinity to EphA4-LBD (unknown origin) by ITC assay	B	C#CCCCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCCNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCO)NC(=O)[C@H](CCCC)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)COc1ccc(F)c(Cl)c1)C(C)C)C(=O)NCC(N)=O		CHEMBL4227953		Activity			CHEMBL3988	Homo sapiens	Activity		
	18653661	CHEMBL4230073	Inhibition of EPH-A4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL3988	Homo sapiens	INH	%	99.0
	18653662	CHEMBL4230073	Inhibition of EPH-A4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	95.0	CHEMBL3988	Homo sapiens	INH	%	95.0
	18655550	CHEMBL4230685	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	94.0	CHEMBL3988	Homo sapiens	Activity	%	94.0
	18665535	CHEMBL4233317	Inhibition of EphA4 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	nM	10000.0
	18674640	CHEMBL4235347	Inhibition of EphA4 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL3988	Homo sapiens	Ki	nM	10000.0
	18674641	CHEMBL4235347	Inhibition of EphA4 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	10000.0	CHEMBL3988	Homo sapiens	Ki	nM	10000.0
Not Determined	18674642	CHEMBL4235347	Inhibition of EphA4 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3988	Homo sapiens	Ki		
	18751123	CHEMBL4263791	Inhibition of EPH-A4 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	6.0	CHEMBL3988	Homo sapiens	INH	%	6.0
	18751629	CHEMBL4264274	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	96.0	CHEMBL3988	Homo sapiens	Activity	%	96.0
	18784707	CHEMBL4271247	Binding affinity to EphA4 ligand binding domain (unknown origin) by ITC	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	=	Kd	nM	420.0	CHEMBL3988	Homo sapiens	Kd	nM	420.0
	18784708	CHEMBL4271247	Binding affinity to EphA4 ligand binding domain (unknown origin) by ITC	B	NCCC(=O)N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)N[C@@H](Cc1ccc(Cl)cc1)C(=O)N[C@@H](Cc1ccncc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4293172	=	Kd	nM	1200.0	CHEMBL3988	Homo sapiens	Kd	nM	1200.0
	18857943	CHEMBL4307789	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18892867	CHEMBL4314833	Inhibition of recombinant human EphA4 (601 to 892 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	18919358	CHEMBL4322732	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHA4 (unknown origin) (586 to 986 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	1096.0	CHEMBL3988	Homo sapiens	Kd	nM	1096.0
Not Determined	18919372	CHEMBL4322732	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHA4 (unknown origin) (586 to 986 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL3988	Homo sapiens	Kd		
	18937889	CHEMBL4327675	Inhibition of human EPHA4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	104.78	CHEMBL3988	Homo sapiens	Activity	%	104.78
	18937890	CHEMBL4327675	Inhibition of human EPHA4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.08	CHEMBL3988	Homo sapiens	Activity	%	100.08
	18938515	CHEMBL4328035	Inhibition of human EPHA4 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3988	Homo sapiens	Activity	%	65.0
	18938893	CHEMBL4328399	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	12.5	CHEMBL3988	Homo sapiens	IC50	10'-8M	1.25
	18958860	CHEMBL4333379	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	18964263	CHEMBL4335069	Inhibition of recombinant human EphA4 (601 to 892 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL3988	Homo sapiens	Activity	%	103.0
	18964264	CHEMBL4335069	Inhibition of recombinant human EphA4 (601 to 892 residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL3988	Homo sapiens	Activity	%	98.0
	18971886	CHEMBL4336896	Inhibition of recombinant human EphA4 (601 to 892 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	81.0	CHEMBL3988	Homo sapiens	Activity	%	81.0
Not Active	19039795	CHEMBL4351847	Inhibition of recombinant human EphA4 (601 to 892 residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
Active	19041093	CHEMBL4352354	Inhibition of human EPHA4 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
	19059562	CHEMBL4357863	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	75.0	CHEMBL3988	Homo sapiens	Activity	%	75.0
	19090133	CHEMBL4365707	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	80.0	CHEMBL3988	Homo sapiens	Activity	%	80.0
	19091908	CHEMBL4366382	Inhibition of human EPHA4 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	6.1	CHEMBL3988	Homo sapiens	INH	%	6.1
	19144785	CHEMBL4377801	Inhibition of recombinant human EphA4 (601 to 892 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	1.0	CHEMBL3988	Homo sapiens	INH	%	1.0
	19147837	CHEMBL4379311	Inhibition of recombinant human EphA4 (601 to 892 residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	19159390	CHEMBL4382494	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	80.0	CHEMBL3988	Homo sapiens	Activity	%	80.0
	19191617	CHEMBL4389213	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	98.0	CHEMBL3988	Homo sapiens	INH	%	98.0
	19191876	CHEMBL4389690	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL3988	Homo sapiens	INH	%	100.0
	19199906	CHEMBL4391316	Binding affinity to wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	19266404	CHEMBL4405354	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3988	Homo sapiens	INH	%	50.0
	19275984	CHEMBL4407987	Inhibition of recombinant human EPhA4 (601 to 892 residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	28.0	CHEMBL3988	Homo sapiens	INH	%	28.0
	19303759	CHEMBL4414211	Inhibition of EPHA4 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	45.0	CHEMBL3988	Homo sapiens	Activity	%	45.0
	19303819	CHEMBL4414211	Inhibition of EPHA4 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	27.0	CHEMBL3988	Homo sapiens	Activity	%	27.0
	19448893	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4449863	=	Kd	nM	45.0	CHEMBL3988	Homo sapiens	Kd	nM	45.0
	19448894	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4436732	=	IC50	nM	27.0	CHEMBL3988	Homo sapiens	IC50	nM	27.0
	19448895	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4447628	=	IC50	nM	38.0	CHEMBL3988	Homo sapiens	IC50	nM	38.0
	19448896	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)Cc2ccc(O)cc2)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4476251	=	IC50	nM	1200.0	CHEMBL3988	Homo sapiens	IC50	nM	1200.0
	19448897	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)NC1=O		CHEMBL4591478	=	IC50	nM	920.0	CHEMBL3988	Homo sapiens	IC50	nM	920.0
	19448898	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)NC1=O		CHEMBL4442705	=	IC50	nM	450.0	CHEMBL3988	Homo sapiens	IC50	nM	450.0
	19448899	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4474623	=	IC50	nM	230.0	CHEMBL3988	Homo sapiens	IC50	nM	230.0
	19448900	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCC(=O)N2)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4569881	=	IC50	nM	290.0	CHEMBL3988	Homo sapiens	IC50	nM	290.0
	19448901	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CCCCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4520376	=	IC50	nM	260.0	CHEMBL3988	Homo sapiens	IC50	nM	260.0
	19448902	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)Cc2cnc[nH]2)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4522324	=	IC50	nM	480.0	CHEMBL3988	Homo sapiens	IC50	nM	480.0
	19448903	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCCCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4436577	=	IC50	nM	83.0	CHEMBL3988	Homo sapiens	IC50	nM	83.0
	19448904	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4434643	=	IC50	nM	54.0	CHEMBL3988	Homo sapiens	IC50	nM	54.0
	19448905	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4458170	=	IC50	nM	34.0	CHEMBL3988	Homo sapiens	IC50	nM	34.0
	19448906	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4440005	=	IC50	nM	25.0	CHEMBL3988	Homo sapiens	IC50	nM	25.0
	19448907	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4516686	=	IC50	nM	41.0	CHEMBL3988	Homo sapiens	IC50	nM	41.0
	19448908	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CNCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C(C)C)NC1=O		CHEMBL4539149	=	IC50	nM	40.0	CHEMBL3988	Homo sapiens	IC50	nM	40.0
	19448909	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4449863	=	IC50	nM	50.0	CHEMBL3988	Homo sapiens	IC50	nM	50.0
	19448910	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4462106	=	IC50	nM	12.0	CHEMBL3988	Homo sapiens	IC50	nM	12.0
	19448911	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464855	=	IC50	nM	22.0	CHEMBL3988	Homo sapiens	IC50	nM	22.0
	19448912	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4530593	=	IC50	nM	12.0	CHEMBL3988	Homo sapiens	IC50	nM	12.0
	19448913	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4468291	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	nM	10000.0
	19448935	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4436732	=	Kd	nM	30.0	CHEMBL3988	Homo sapiens	Kd	nM	30.0
	19448936	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464968	=	Kd	nM	27.0	CHEMBL3988	Homo sapiens	Kd	nM	27.0
Not Determined	19448937	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4462106		Kd			CHEMBL3988	Homo sapiens	Kd		
Not Determined	19448938	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464855		Kd			CHEMBL3988	Homo sapiens	Kd		
	19448939	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4530593	=	Kd	nM	19.0	CHEMBL3988	Homo sapiens	Kd	nM	19.0
Not Determined	19448940	CHEMBL4433137	Binding affinity to 6His-tagged EphA4 C204A mutant (29 to 104 residues) (unknown origin) expressed in Escherichia coli Origami 2 (DE3) by isothermal titration calorimetry	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4468291		Kd			CHEMBL3988	Homo sapiens	Kd		
	19448941	CHEMBL4433138	Inhibition of 0.5 ug/ml ephrinA5-induced human EphA4 tyrosine phosphorylation expressed in HEK293AD cells preincubated for 20 mins followed by ephrinA5 stimulation for 20 mins by immunoblot analysis	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464968	=	IC50	nM	240.0	CHEMBL3988	Homo sapiens	IC50	uM	0.24
Active	19448958	CHEMBL4433155	Antagonist activity against EphA4 receptor E77A mutant (unknown origin) expressed in Escherichia coli Origami 2 (DE3) assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464968		Inhibition	%		CHEMBL3988	Homo sapiens	INH		
	19448959	CHEMBL4433154	Inhibition of 0.4 ug/ml ephrinA5-induced human EphA4 tyrosine phosphorylation expressed in HEK293AD cells preincubated for 20 mins followed by ephrinA5 stimulation for 20 mins by immunoblot analysis	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4530593	=	IC50	nM	310.0	CHEMBL3988	Homo sapiens	IC50	uM	0.31
	19448961	CHEMBL4433135	Antagonist activity against human EphA4 receptor assessed as inhibition of binding of alkaline phosphatase-fused ephrin-A5 to immobilized EphA4 Fc by ELISA	B	CC(C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H]2CCCN2C(=O)CCN)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4464968	=	IC50	nM	17.0	CHEMBL3988	Homo sapiens	IC50	nM	17.0
	20600518	CHEMBL4603470	Inhibition of recombinant human GST-tagged EPHA4 cytoplasmic domain expressed in baculovirus expression system using tyrosine-02 peptide as substrate incubated for 60 mins in presence of ATP by Z'-Lyte assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL3988	Homo sapiens	IC50	uM	100.0
	22391794	CHEMBL4667004	Inhibition of recombinant human GST-tagged EPHA4 (616 to 887 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	-4.0	CHEMBL3988	Homo sapiens	INH	%	-4.0
	22391795	CHEMBL4667004	Inhibition of recombinant human GST-tagged EPHA4 (616 to 887 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	4.0	CHEMBL3988	Homo sapiens	INH	%	4.0
	22391796	CHEMBL4667004	Inhibition of recombinant human GST-tagged EPHA4 (616 to 887 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	3.0	CHEMBL3988	Homo sapiens	INH	%	3.0
	22423109	CHEMBL4674124	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL3988	Homo sapiens	INH	%	80.0
	22423657	CHEMBL4674404	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	72.69	CHEMBL3988	Homo sapiens	Activity	%	72.69
	22423658	CHEMBL4674404	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	90.75	CHEMBL3988	Homo sapiens	Activity	%	90.75
	22822938	CHEMBL4716847	Inhibition of EphA4 (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	>	IC50	nM	10000.0	CHEMBL3988	Homo sapiens	IC50	uM	10.0
	22843764	CHEMBL4720750	Inhibition of human EPHA4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.5	CHEMBL3988	Homo sapiens	IC50	10^-9M	8.5
	22844117	CHEMBL4721103	Inhibition of human EPHA4 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	79.93	CHEMBL3988	Homo sapiens	Activity	%	79.93
	22844692	CHEMBL4721367	Inhibition of wild-type human partial length EPHA4 (T601 to R897 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	106.64	CHEMBL3988	Homo sapiens	Activity	%	106.64
	22950617	CHEMBL4766184	Inhibition of human recombinant EPHA4 (601 to 892 residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	227.0	CHEMBL3988	Homo sapiens	IC50	uM	0.22699999999999998
	22952825	CHEMBL4766762	Inhibition of recombinant human EphA4 (601 to 892 residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	29.0	CHEMBL3988	Homo sapiens	Activity	%	29.0
	23122548	CHEMBL4804899	Inhibition of human EPHA4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL3988	Homo sapiens	Activity	%	93.0
	23123243	CHEMBL4805487	Inhibition of human EPHA4 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	23123648	CHEMBL4805892	Inhibition of DNA-tagged human EPHA4 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	23124576	CHEMBL4806504	Inhibition of human EPHA4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	23124577	CHEMBL4806504	Inhibition of human EPHA4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL3988	Homo sapiens	Activity	%	100.0
	23127407	CHEMBL4807594	Inhibition of EPHA4 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	10.0	CHEMBL3988	Homo sapiens	Activity	%	10.0
	23127408	CHEMBL4807594	Inhibition of EPHA4 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	8.0	CHEMBL3988	Homo sapiens	Activity	%	8.0
	23128053	CHEMBL4807826	Inhibition of EPHA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL3988	Homo sapiens	Activity	%	25.0
	23128054	CHEMBL4807826	Inhibition of EPHA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL3988	Homo sapiens	Activity	%	25.0
	23128055	CHEMBL4807826	Inhibition of EPHA4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL3988	Homo sapiens	Activity	%	25.0
	23128789	CHEMBL4808062	Inhibition of EPHA4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	92.0	CHEMBL3988	Homo sapiens	INH	%	92.0
	23128790	CHEMBL4808062	Inhibition of EPHA4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	18.0	CHEMBL3988	Homo sapiens	INH	%	18.0
	23128791	CHEMBL4808062	Inhibition of EPHA4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	38.0	CHEMBL3988	Homo sapiens	INH	%	38.0
	23223108	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O		CHEMBL4868727	=	Kd	nM	3022.0	CHEMBL3988	Homo sapiens	Kd	nM	3022.0
	23223109	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCN)C(N)=O		CHEMBL4864648	=	Kd	nM	2130.0	CHEMBL3988	Homo sapiens	Kd	nM	2130.0
	23223110	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4870085	=	Kd	nM	663.0	CHEMBL3988	Homo sapiens	Kd	nM	663.0
	23223111	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4876759	=	Kd	nM	352.0	CHEMBL3988	Homo sapiens	Kd	nM	352.0
	23223112	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CCC[C@@H](N)C1)C(N)=O		CHEMBL4869742	=	Kd	nM	1211.0	CHEMBL3988	Homo sapiens	Kd	nM	1211.0
	23223113	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(N)=O		CHEMBL4866293	=	Kd	nM	370.0	CHEMBL3988	Homo sapiens	Kd	nM	370.0
	23223114	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CC[C@@H](N)C1)C(N)=O		CHEMBL4876097	=	Kd	nM	740.0	CHEMBL3988	Homo sapiens	Kd	nM	740.0
	23223115	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CC[C@H](N)C1)C(N)=O		CHEMBL4863427	=	Kd	nM	1117.0	CHEMBL3988	Homo sapiens	Kd	nM	1117.0
	23223116	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccc2[nH]cc(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c2c1		CHEMBL4870730	=	Kd	nM	444.0	CHEMBL3988	Homo sapiens	Kd	nM	444.0
	23223117	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccc2c(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c[nH]c2c1		CHEMBL4870758	=	Kd	nM	2463.0	CHEMBL3988	Homo sapiens	Kd	nM	2463.0
	23223118	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ncccc12)NC(=O)CCCN)C(N)=O		CHEMBL4865286	=	Kd	nM	16280.0	CHEMBL3988	Homo sapiens	Kd	nM	16280.0
	23223119	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4865344	=	Kd	nM	11050.0	CHEMBL3988	Homo sapiens	Kd	nM	11050.0
	23223120	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4846239	=	Kd	nM	5250.0	CHEMBL3988	Homo sapiens	Kd	nM	5250.0
	23223121	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccc(Cl)cc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4857565	=	Kd	nM	749.0	CHEMBL3988	Homo sapiens	Kd	nM	749.0
	23223122	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	Cc1ccc(-c2ccc(C[C@H](NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc2)cc1		CHEMBL4870110	=	Kd	nM	708.0	CHEMBL3988	Homo sapiens	Kd	nM	708.0
	23223123	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	Cc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4862398	=	Kd	nM	362.0	CHEMBL3988	Homo sapiens	Kd	nM	362.0
	23223124	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4869466	=	Kd	nM	196.0	CHEMBL3988	Homo sapiens	Kd	nM	196.0
	23223125	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4849818	=	Kd	nM	1094.0	CHEMBL3988	Homo sapiens	Kd	nM	1094.0
	23223126	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)Nc1ccc(C[C@H](NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCN)C(N)=O)cc1		CHEMBL4862634	=	Kd	nM	1156.0	CHEMBL3988	Homo sapiens	Kd	nM	1156.0
	23223127	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4872516	=	Kd	nM	270.0	CHEMBL3988	Homo sapiens	Kd	nM	270.0
	23223128	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4849028	=	Kd	nM	459.0	CHEMBL3988	Homo sapiens	Kd	nM	459.0
	23223129	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4874658	=	Kd	nM	437.0	CHEMBL3988	Homo sapiens	Kd	nM	437.0
	23223130	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ncccc1O		CHEMBL4859816	=	Kd	nM	488.0	CHEMBL3988	Homo sapiens	Kd	nM	488.0
	23223131	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1		CHEMBL4848686	=	Kd	nM	132.0	CHEMBL3988	Homo sapiens	Kd	nM	132.0
	23223132	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1cc(CNC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)cc(OC)c1		CHEMBL4857984	=	Kd	nM	307.0	CHEMBL3988	Homo sapiens	Kd	nM	307.0
	23223133	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)NCc1ccccc1O		CHEMBL4853012	=	Kd	nM	258.0	CHEMBL3988	Homo sapiens	Kd	nM	258.0
	23223134	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1O		CHEMBL4850403	=	Kd	nM	191.0	CHEMBL3988	Homo sapiens	Kd	nM	191.0
	23223135	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4846015	=	Kd	nM	94.0	CHEMBL3988	Homo sapiens	Kd	nM	94.0
	23223136	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4872754	=	Kd	nM	106.0	CHEMBL3988	Homo sapiens	Kd	nM	106.0
	23223137	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905	=	Kd	nM	77.0	CHEMBL3988	Homo sapiens	Kd	nM	77.0
	23223138	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333	=	Kd	nM	144.0	CHEMBL3988	Homo sapiens	Kd	nM	144.0
	23223139	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331	=	Kd	nM	106.0	CHEMBL3988	Homo sapiens	Kd	nM	106.0
	23223140	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	=	Kd	nM	113.0	CHEMBL3988	Homo sapiens	Kd	nM	113.0
	23223141	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	=	Kd	nM	400.0	CHEMBL3988	Homo sapiens	Kd	nM	400.0
	23223142	CHEMBL4825025	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by isothermal titration calorimetry	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061	=	Kd	nM	60.0	CHEMBL3988	Homo sapiens	Kd	nM	60.0
Not Active	23223143	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O		CHEMBL4868727		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223144	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCN)C(N)=O		CHEMBL4864648	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223145	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4870085	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223146	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4876759	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
Not Active	23223147	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CCC[C@@H](N)C1)C(N)=O		CHEMBL4869742		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223148	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(N)=O		CHEMBL4866293	=	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
Not Active	23223149	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CC[C@@H](N)C1)C(N)=O		CHEMBL4876097		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223150	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CC[C@H](N)C1)C(N)=O		CHEMBL4863427		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223151	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccc2[nH]cc(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c2c1		CHEMBL4870730	=	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
Not Active	23223152	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccc2c(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c[nH]c2c1		CHEMBL4870758		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223153	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ncccc12)NC(=O)CCCN)C(N)=O		CHEMBL4865286		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223154	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4865344		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223155	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4846239		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223156	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccc(Cl)cc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4857565	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
Not Active	23223157	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	Cc1ccc(-c2ccc(C[C@H](NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc2)cc1		CHEMBL4870110		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223158	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	Cc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4862398	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223159	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4869466	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
Not Active	23223160	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4849818		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223161	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)Nc1ccc(C[C@H](NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCN)C(N)=O)cc1		CHEMBL4862634		Activity			CHEMBL3988	Homo sapiens	Activity		
Not Active	23223162	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4872516		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223163	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4849028	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223164	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4874658	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223165	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ncccc1O		CHEMBL4859816	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223166	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1		CHEMBL4848686	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223167	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1cc(CNC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)cc(OC)c1		CHEMBL4857984	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223168	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)NCc1ccccc1O		CHEMBL4853012	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223169	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1O		CHEMBL4850403	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223170	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4846015	>	Activity	ppm	0.25	CHEMBL3988	Homo sapiens	Activity	ppm	0.25
	23223171	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4872754	<	Activity	ppm	0.2	CHEMBL3988	Homo sapiens	Activity	ppm	0.2
	23223172	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223173	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333	=	Activity	ppm	0.2	CHEMBL3988	Homo sapiens	Activity	ppm	0.2
	23223174	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223175	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	<	Activity	ppm	0.2	CHEMBL3988	Homo sapiens	Activity	ppm	0.2
	23223176	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223177	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223178	CHEMBL4825026	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 164 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	>	Activity	ppm	0.25	CHEMBL3988	Homo sapiens	Activity	ppm	0.25
	23223197	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223198	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223199	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223200	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223201	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223202	CHEMBL4825030	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 115 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061	>	Activity	ppm	0.25	CHEMBL3988	Homo sapiens	Activity	ppm	0.25
	23223203	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(CN3CCOCC3)cc2)cc1		CHEMBL4853905	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223204	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4853333	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223205	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)[C@H]2CCC[C@H](N)C2)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NCC(=O)Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL4879331	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223206	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183	<	Activity	ppm	0.1	CHEMBL3988	Homo sapiens	Activity	ppm	0.1
	23223207	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](Cc3ccncc3)NC(=O)[C@H](Cc3ccc(Cl)cc3)NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)c2c1		CHEMBL4293477	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
	23223208	CHEMBL4825031	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in chemical shift perturbation at Met 60 residues at 40 uM by 2D-[13C-1H] HSQC NMR spectroscopy	B	CC(C)[C@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C(=O)CCN)CSSC[C@H](C(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](CO)NC(=O)CCNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL4878061	<	Activity	ppm	0.0	CHEMBL3988	Homo sapiens	Activity	ppm	0.0
Active	23223209	CHEMBL4825032	Displacement of EphrinA5 from N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells by 2D-[13C-1H] HSQC NMR spectroscopy	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4865183		Activity			CHEMBL3988	Homo sapiens	Activity		
	23223215	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O		CHEMBL4868727	=	deltaH	kcal/mol	-9.54	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.54
	23223216	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCN)C(N)=O		CHEMBL4864648	=	deltaH	kcal/mol	-11.5	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.5
	23223217	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4870085	=	deltaH	kcal/mol	-10.7	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.7
	23223218	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4876759	=	deltaH	kcal/mol	-11.59	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.59
	23223219	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CCC[C@@H](N)C1)C(N)=O		CHEMBL4869742	=	deltaH	kcal/mol	-9.39	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.39
	23223220	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(N)=O		CHEMBL4866293	=	deltaH	kcal/mol	-8.1	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-8.1
	23223221	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CC[C@@H](N)C1)C(N)=O		CHEMBL4876097	=	deltaH	kcal/mol	-9.82	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.82
	23223222	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CC[C@H](N)C1)C(N)=O		CHEMBL4863427	=	deltaH	kcal/mol	-8.33	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-8.33
	23223223	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	COc1ccc2[nH]cc(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c2c1		CHEMBL4870730	=	deltaH	kcal/mol	-10.56	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.56
	23223224	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	COc1ccc2c(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c[nH]c2c1		CHEMBL4870758	=	deltaH	kcal/mol	-10.49	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.49
	23223225	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ncccc12)NC(=O)CCCN)C(N)=O		CHEMBL4865286	=	deltaH	kcal/mol	-7.27	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-7.27
	23223226	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4865344	=	deltaH	kcal/mol	-8.22	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-8.22
	23223227	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4846239	=	deltaH	kcal/mol	-8.49	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-8.49
	23223228	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccc(Cl)cc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4857565	=	deltaH	kcal/mol	-10.36	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.36
	23223229	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	Cc1ccc(-c2ccc(C[C@H](NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc2)cc1		CHEMBL4870110	=	deltaH	kcal/mol	-10.16	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.16
	23223230	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	Cc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4862398	=	deltaH	kcal/mol	-12.08	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-12.08
	23223231	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4869466	=	deltaH	kcal/mol	-12.29	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-12.29
	23223232	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4849818	=	deltaH	kcal/mol	-10.73	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.73
	23223233	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)Nc1ccc(C[C@H](NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCN)C(N)=O)cc1		CHEMBL4862634	=	deltaH	kcal/mol	-9.43	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.43
	23223234	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4872516	=	deltaH	kcal/mol	-9.26	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.26
	23223235	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4849028	=	deltaH	kcal/mol	-10.99	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.99
	23223236	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4874658	=	deltaH	kcal/mol	-11.21	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.21
	23223237	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ncccc1O		CHEMBL4859816	=	deltaH	kcal/mol	-9.48	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-9.48
	23223238	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1		CHEMBL4848686	=	deltaH	kcal/mol	-12.26	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-12.26
	23223239	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	COc1cc(CNC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)cc(OC)c1		CHEMBL4857984	=	deltaH	kcal/mol	-11.27	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.27
	23223240	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)NCc1ccccc1O		CHEMBL4853012	=	deltaH	kcal/mol	-11.98	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.98
	23223241	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1O		CHEMBL4850403	=	deltaH	kcal/mol	-12.04	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-12.04
	23223242	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4846015	=	deltaH	kcal/mol	-11.22	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-11.22
	23223243	CHEMBL4825038	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in enthalpy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4872754	=	deltaH	kcal/mol	-10.56	CHEMBL3988	Homo sapiens	deltaH	kcal/mol	-10.56
	23223244	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	C[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O		CHEMBL4868727	=	-TdeltaS	kcal/mol	2.01	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.01
	23223245	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCN)C(N)=O		CHEMBL4864648	=	-TdeltaS	kcal/mol	3.77	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	3.77
	23223246	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4870085	=	-TdeltaS	kcal/mol	2.27	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.27
	23223247	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4876759	=	-TdeltaS	kcal/mol	2.79	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.79
	23223248	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CCC[C@@H](N)C1)C(N)=O		CHEMBL4869742	=	-TdeltaS	kcal/mol	1.32	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.32
	23223249	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CCC[C@H](N)C1)C(N)=O		CHEMBL4866293	=	-TdeltaS	kcal/mol	-0.67	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	-0.67
	23223250	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@@H]1CC[C@@H](N)C1)C(N)=O		CHEMBL4876097	=	-TdeltaS	kcal/mol	1.46	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.46
	23223251	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)[C@H]1CC[C@H](N)C1)C(N)=O		CHEMBL4863427	=	-TdeltaS	kcal/mol	0.21	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	0.21
	23223252	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	COc1ccc2[nH]cc(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c2c1		CHEMBL4870730	=	-TdeltaS	kcal/mol	1.9	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.9
	23223253	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	COc1ccc2c(C[C@H](NC(=O)CCCN)C(=O)N[C@@H](Cc3ccc(-c4ccccc4)cc3)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)c[nH]c2c1		CHEMBL4870758	=	-TdeltaS	kcal/mol	2.84	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.84
	23223254	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ncccc12)NC(=O)CCCN)C(N)=O		CHEMBL4865286	=	-TdeltaS	kcal/mol	0.74	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	0.74
	23223255	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4865344	=	-TdeltaS	kcal/mol	1.46	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.46
	23223256	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4846239	=	-TdeltaS	kcal/mol	1.27	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.27
	23223257	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccc(Cl)cc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4857565	=	-TdeltaS	kcal/mol	2.0	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.0
	23223258	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	Cc1ccc(-c2ccc(C[C@H](NC(=O)[C@H](Cc3c[nH]c4ccc(O)cc34)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc2)cc1		CHEMBL4870110	=	-TdeltaS	kcal/mol	1.77	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.77
	23223259	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	Cc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4862398	=	-TdeltaS	kcal/mol	3.29	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	3.29
	23223260	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	COc1ccccc1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4869466	=	-TdeltaS	kcal/mol	3.14	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	3.14
	23223261	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	COc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)C(=O)N[C@@H](CCCCNC(=N)N)C(N)=O)cc1		CHEMBL4849818	=	-TdeltaS	kcal/mol	2.6	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.6
	23223262	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)Nc1ccc(C[C@H](NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)CCCN)C(N)=O)cc1		CHEMBL4862634	=	-TdeltaS	kcal/mol	1.33	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.33
	23223263	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCCN)C(N)=O		CHEMBL4872516	=	-TdeltaS	kcal/mol	0.3	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	0.3
	23223264	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4849028	=	-TdeltaS	kcal/mol	2.35	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.35
	23223265	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(N)=O		CHEMBL4874658	=	-TdeltaS	kcal/mol	2.54	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.54
	23223266	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ncccc1O		CHEMBL4859816	=	-TdeltaS	kcal/mol	0.86	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	0.86
	23223267	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1		CHEMBL4848686	=	-TdeltaS	kcal/mol	2.87	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.87
	23223268	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	COc1cc(CNC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)[C@H](Cc2ccc(-c3ccccc3)cc2)NC(=O)[C@H](Cc2c[nH]c3ccc(O)cc23)NC(=O)CCCN)cc(OC)c1		CHEMBL4857984	=	-TdeltaS	kcal/mol	2.39	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.39
	23223269	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)NCc1ccccc1O		CHEMBL4853012	=	-TdeltaS	kcal/mol	3.0	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	3.0
	23223270	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccccc1O		CHEMBL4850403	=	-TdeltaS	kcal/mol	2.88	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	2.88
	23223271	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(N2CCOCC2)cc1		CHEMBL4846015	=	-TdeltaS	kcal/mol	1.63	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.63
	23223272	CHEMBL4825039	Binding affinity to N-terminal His tagged EphA4 LBD (unknown origin) (29 to 209 residues) expressed in Rosetta-Gami B(DE3) cells assessed as change in entropy by isothermal titration calorimetry	B	N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccc(O)cc12)NC(=O)CCCN)C(=O)NCC(=O)Nc1ccc(CN2CCOCC2)cc1		CHEMBL4872754	=	-TdeltaS	kcal/mol	1.05	CHEMBL3988	Homo sapiens	-TdeltaS	kcal/mol	1.05
Not Active	23317383	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	74.0	CHEMBL3988	Homo sapiens	% Control	%	74.0
Not Active	23317851	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23318520	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Active	23319001	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	12.0	CHEMBL3988	Homo sapiens	% Control	%	12.0
Not Active	23319638	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23320113	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	95.7	CHEMBL3988	Homo sapiens	% Control	%	95.7
Not Active	23320791	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23321259	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23321889	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL3988	Homo sapiens	% Control	%	97.0
Not Active	23322357	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	75.0	CHEMBL3988	Homo sapiens	% Control	%	75.0
Not Active	23323046	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23323514	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	91.0	CHEMBL3988	Homo sapiens	% Control	%	91.0
Not Active	23323997	CHEMBL4880616	EphA4 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-5.0	CHEMBL3988	Homo sapiens	% inhibition	%	-5.0
Not Active	23324368	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	96.4	CHEMBL3988	Homo sapiens	% Control	%	96.4
Not Active	23325003	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	90.0	CHEMBL3988	Homo sapiens	% Control	%	90.0
Not Active	23325471	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL3988	Homo sapiens	% Control	%	92.0
Not Active	23326118	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	97.0	CHEMBL3988	Homo sapiens	% Control	%	97.0
Not Active	23326586	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23327286	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23327754	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL3988	Homo sapiens	% Control	%	97.0
Not Active	23328341	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	99.0	CHEMBL3988	Homo sapiens	% Control	%	99.0
Not Active	23328809	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23329330	CHEMBL4881037	EphA4(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	82.0	CHEMBL3988	Homo sapiens	% residual kinase activity	%	82.0
Not Active	23329755	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23330223	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23330979	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23331447	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23332034	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23332500	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	76.0	CHEMBL3988	Homo sapiens	% Control	%	76.0
Not Active	23333218	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23333857	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	79.0	CHEMBL3988	Homo sapiens	% Control	%	79.0
Not Active	23334325	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23335304	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23335772	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23336399	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	82.0	CHEMBL3988	Homo sapiens	% Control	%	82.0
Not Active	23336867	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	98.0	CHEMBL3988	Homo sapiens	% Control	%	98.0
Not Active	23337582	CHEMBL4881953	EPHA4 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.0	CHEMBL3988	Homo sapiens	% Ctrl	%	95.0
Not Active	23337948	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23338416	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23339028	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23339496	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL3988	Homo sapiens	% Control	%	95.0
Not Active	23340133	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23340601	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23341258	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23341726	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23342342	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	79.0	CHEMBL3988	Homo sapiens	% Control	%	79.0
Not Active	23342810	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23343440	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	96.0	CHEMBL3988	Homo sapiens	% Control	%	96.0
Not Active	23343908	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23344546	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	91.0	CHEMBL3988	Homo sapiens	% Control	%	91.0
Not Active	23345119	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23345587	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	93.0	CHEMBL3988	Homo sapiens	% Control	%	93.0
Not Active	23346164	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	78.6	CHEMBL3988	Homo sapiens	% Control	%	78.6
Not Active	23346633	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23347241	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23347724	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	61.0	CHEMBL3988	Homo sapiens	% Control	%	61.0
Not Active	23348303	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	96.0	CHEMBL3988	Homo sapiens	% Control	%	96.0
Not Active	23348771	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	98.0	CHEMBL3988	Homo sapiens	% Control	%	98.0
Not Active	23349358	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	95.0	CHEMBL3988	Homo sapiens	% Control	%	95.0
Not Active	23349976	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23350444	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	92.0	CHEMBL3988	Homo sapiens	% Control	%	92.0
Not Active	23351049	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	87.0	CHEMBL3988	Homo sapiens	% Control	%	87.0
Not Active	23351517	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	93.0	CHEMBL3988	Homo sapiens	% Control	%	93.0
Not Active	23352033	CHEMBL4882724	EPHA4 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	4.817	CHEMBL3988	Homo sapiens	% Inhibition	%	4.8168
Not Active	23352541	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	89.0	CHEMBL3988	Homo sapiens	% Control	%	89.0
Not Active	23353009	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23353891	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23354359	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23355091	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23355559	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23356195	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23356663	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23357272	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	92.0	CHEMBL3988	Homo sapiens	% Control	%	92.0
Not Active	23357919	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23358387	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23358973	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	91.1	CHEMBL3988	Homo sapiens	% Control	%	91.1
Not Active	23359571	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	65.0	CHEMBL3988	Homo sapiens	% Control	%	65.0
Not Active	23360039	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	90.0	CHEMBL3988	Homo sapiens	% Control	%	90.0
Not Active	23360624	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	97.0	CHEMBL3988	Homo sapiens	% Control	%	97.0
Not Active	23361092	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23361665	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23362201	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	96.0	CHEMBL3988	Homo sapiens	% Control	%	96.0
Not Active	23362669	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23364311	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	88.0	CHEMBL3988	Homo sapiens	% Control	%	88.0
Not Active	23364779	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23365518	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	88.0	CHEMBL3988	Homo sapiens	% Control	%	88.0
Not Active	23366061	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23366651	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23367119	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	70.0	CHEMBL3988	Homo sapiens	% Control	%	70.0
Not Active	23367555	CHEMBL4883908	EPHA4 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	93.0	CHEMBL3988	Homo sapiens	% Residual activity with Skepinone-L	%	93.0
Not Active	23367997	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	88.0	CHEMBL3988	Homo sapiens	% Control	%	88.0
Not Active	23368465	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23369064	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	98.0	CHEMBL3988	Homo sapiens	% Control	%	98.0
Not Active	23369532	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	92.0	CHEMBL3988	Homo sapiens	% Control	%	92.0
Not Active	23370052	CHEMBL4884296	EphA4(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	106.0	CHEMBL3988	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23370500	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23370968	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	93.0	CHEMBL3988	Homo sapiens	% Control	%	93.0
Not Active	23371777	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	98.0	CHEMBL3988	Homo sapiens	% Control	%	98.0
Not Active	23372245	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	76.0	CHEMBL3988	Homo sapiens	% Control	%	76.0
	23372732	CHEMBL4884697	EphA4(EPA4LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3988	Homo sapiens	pIC50		6.0
	23373141	CHEMBL4884988	EphA4(EPA4LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3988	Homo sapiens	pIC50		6.0
	23373502	CHEMBL4885279	EphA4(EPA4LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3988	Homo sapiens	pIC50		6.0
Not Active	23375237	CHEMBL4886219	EPH receptor A4 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	2.0	CHEMBL3988	Homo sapiens	% inhibition	%	2.0
Not Active	23375672	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	84.0	CHEMBL3988	Homo sapiens	% Control	%	84.0
Not Active	23376140	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23376717	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23377186	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	89.0	CHEMBL3988	Homo sapiens	% Control	%	89.0
Not Active	23378045	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	89.0	CHEMBL3988	Homo sapiens	% Control	%	89.0
Not Active	23378513	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	86.0	CHEMBL3988	Homo sapiens	% Control	%	86.0
Not Active	23379680	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	79.0	CHEMBL3988	Homo sapiens	% Control	%	79.0
Not Active	23380148	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	89.0	CHEMBL3988	Homo sapiens	% Control	%	89.0
Not Active	23380842	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23381490	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23381958	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
Not Active	23382582	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	99.0	CHEMBL3988	Homo sapiens	% Control	%	99.0
Not Active	23383050	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	90.0	CHEMBL3988	Homo sapiens	% Control	%	90.0
Not Active	23383776	CHEMBL4887415	EPHA4 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL3988	Homo sapiens	% Ctrl	%	93.0
Not Active	23384261	CHEMBL4887856	EphA4(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-16.84	CHEMBL3988	Homo sapiens	% inhibition	%	-16.84
Not Active	23384650	CHEMBL4888176	EPHB4 SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	7.0	CHEMBL3988	Homo sapiens	% Inhibition	%	7.0
Not Active	23384965	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	83.0	CHEMBL3988	Homo sapiens	% Control	%	83.0
Not Active	23385432	CHEMBL4879689	KinomeScan assay: inhibition of EPHA4	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3988	Homo sapiens	% Control	%	100.0
